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Chapter 1 
 
General Introduction  
  
 
1.1. Wound Care 
 
 
1.1.1. Wound Dressing 
 
 Wound care after accidents and/or surgery requires quick hemostasis. In many cases, sutures are applied 
to occlude the wound; however, tissues with high fluid and/or gas pressure, such as the aorta and intestine, require 
further treatment to the prevent leakage from the area (Figure 1.1).  
 
Intestine, Aorta etc.
Open Wound
No Leakage
Suture
Blood, Air etc. Oozing
+Wound Dressing
 
Figure 1.1. Wound care. 
 
Wound dressing has been widely applied to quicken hemostasis, to supply a moist environment around the 
wounds, and to reinforce the sutured site. There are several wound dressings in practical use, including 
hydrocolloid, polyurethane foam, alginate, hydrogel, and hydropolymer materials1. Currently, the application of 
these manufactured products is not intended for use beyond hemostasis, and several aspects of their application 
can be improved upon. 
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1.2. Adhesives 
 
Today, wound dressings with features beyond hemostasis and fluid/gas leakage prevention are being 
studied1. Dressings with strong adhesion to wet tissue, hemostasis, and reinforcement properties will eventually 
replace sutures and save time in the operating room (Figure 1.2A). Moreover, new materials under investigation 
can bind different tissues and can offer the appropriate environment for tissue/cell proliferation (Figure 1.2B). 
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Figure 1.2. Wound dressing with adhesion ability (A) and the expected roles for adhesives (B). 
 
 
1.2.1. Essences of Adhesives 
 
Adhesives used for surgery have set requirements for their practical application (Table 1.1), and there 
are some critical points that must be improved: bulk strength (crosslinkings and crosslinkers), interfacial 
interaction strength, and composition (polymer morphology and polymer origin). The physical property of 
bonding strength and the following properties are the basic points for adhesion. Preventing infection and 
inflammation are two keys for biomaterials. Resolution of a wound cannot be attained without some immunogenic 
drawbacks in vivo. In addition, materials should possess appropriate biodegradability to not leave a scar upon 
healing. Finally, the handling and cost of the biomaterials must be taken into account.  
 
 
 
 
 
 
(A) 
(B) 
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Table 1.1. Essence for clinical adhesives 
 
Requirements Conditions to be improved
Bonding strength
Following property
Infection prohibition
Inflammation prohibition
Degradability
Handling
Cost
Bulk strength (Crosslinking), Interfacial interaction etc. 
Bulk strength (Crosslinking), Polymer morphology, etc.
Protein derived polymer, Sterilization, Application place etc.
Polymer morphology etc.
Polymer morphology, Crosslinking etc.
Polymer origin, Crosslinker etc.
Polymer origin, Crosslinker etc.  
 
 
1.2.1.1. Bonding Strength 
 
 Bonding strength depends on the bulk strength of adhesives and on the adhesive-tissue interfacial 
strength. These elements are crucial determinants of how adhesion failures occur. Appropriate bulk strength and 
interfacial strength results in cohesive failure inside the adhesive and adherend failure inside the adherend. In 
contrast, with inappropriate bulk strength and interfacial strength, interfacial failure should occur between the 
adhesive and the adherend. A combination of these three failures causes complex failure (Figure 1.3). 
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Figure 1.3. Bonding failure styles. 
 
Adhesives also require similar bulk strength to the adherend, while inappropriate bulk strength induces 
weak adhesion (Table 1.2). 
 
Table 1.2. Relation between bulk/interfacial strength and bonding failure 
Bulk Strength Interfacial Strength Bonding Failure Bonding Strength
Adherend > Adhesive Weak Interfacial WeakStrong Cohesive Weak
Adherend = Adhesive Weak Interfacial WeakStrong Complex Strong
Adherend < Adhesive Weak Interfacial WeakStrong Adherend Weak  
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1.2.1.2. Bulk Strength 
 
As described above, bulk strength is the critical element for adhesives, and bulk strength or material 
stiffness is influenced by the crosslinking level between the adhesive base molecules and by molecular structure. 
 
Crosslinking is crucial for combining adhesive compositions and tissue surface. Moreover, the 
crosslinking level decides both adhesive properties that is required for elastic tissue/organ application and 
adhesive bulk strength (Figure 1.4). Moreover, as described above, bulk strength also results in strong bonding 
ability because strong adhesion requires equivalent stiffness between the adherent and adhesive.  
 
Polymer
Crosslinking


• Low Crosslinking
• Low Bulk Strength
• High Crosslinking
• High Bulk Strength  
Figure 1.4. Crosslinking effect on bulk strength 
 
Table 1.3. Crosslinking methods 
Crosslinking Methods Advantages Disadvantages
Electronic beam crosslinking Simple and easy
Sterilization
Low toxicity
Polymer denaturation
Device requirement
Difficult crosslinking regulation
Gamma ray crosslinking
UV light crosslinking
Cryogelation Low polymer denaturationLow toxicity Time consuming
Thermal crosslinking Simple and easyLow toxicity
Polymer denaturation/degradation
Device-requirement
Difficult crosslinking regulation
Chemical crosslinking Easy crosslinking regulationEasy functional modification
(High toxicity)
Composition alteration  
 
There are several major crosslinking methods such as electronic beam crosslinking, gamma ray 
crosslinking, UV light crosslinking, cryogelation, thermal crosslinking, and chemical crosslinking (Table 1.3). All 
of them have advantages as well as disadvantages.  
 
Chemical crosslinkers can easily regulate the crosslinking level by altering the amount of crosslinker. In 
addition, functional modification of polymers by crosslinkers has been reported. The insertion of the chemical 
compounds and the subsequent generation of byproducts are potential disadvantages.  
 
On the other hand, electronic beam crosslinking, gamma ray crosslinking, UV light crosslinking, and 
thermal crosslinking are simple to execute. These methods mainly release H2O and CO2, and are harmless. In 
addition, electronic beam crosslinking, gamma ray crosslinking, and UV light treatment sterilizes the materials. 
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However, difficulty in crosslinking level, denaturation of some polymers, and the requirement of devices are the 
disadvantages of these methods.  
 
Cryogelation is superior in retaining polymer morphology and has low toxicity at levels reasonable in 
tissues and/or cells. The disadvantage of this method is that it is time consuming and the product has weak bulk 
strength2.  
 
As every method has drawbacks and advantages, the appropriate crosslinking method should be selected 
for each specific purpose3. 
 
 
1.2.1.3. Interfacial Strength 
 
Interfacial interaction is also an important factor in creating strong bonding4. Stronger interfacial 
bonding results from strong interfacial interactions and large regions of interfacial interaction. Forces that drive 
the reinforcement of interface strength include chemical and physiological interactions. These are described in 
section 1.2.2.3. 
 
 
1.2.2. Classification of Adhesives 
 
Current medical adhesives under development can be classified by conformation, composition, and 
conception (Table 1.4). Choosing appropriate conformation and composition is important for effective wound 
treatment. Various conceptions for adhesives have been proposed and studied as follows: 
 
Table 1.4. Classification of adhesives 
Classification Type
Conformation Liquid/Splay
Gel
Powder
Film
Composition Polymer
Crosslinker
Conception Biomimetic
Natural materials
Nano materials  
 
 
1.2.2.1. Adhesive Conformation 
 
 Adhesive conformation is crucial for handling under real-life circumstances. The important point is to 
select the conformation best for the purpose, which may include deep scars, superficial injuries, with/without 
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quantity requirement5. For instant, for small wound liquid adhesives can cover all the area, however, for large 
wound, solid adhesives will be handy to cover the surface.  
 
Liquid/Splay Type Adhesives: Liquid and spray adhesives are superior in adhering with high infiltration 
properties6, and are also  the crosslinking level can be easily regulated. The disadvantage of the liquid/spray type 
adhesives is that their preparation is not trivial. All of the ingredients, including the solvent, base polymer, and 
crosslinker must be mixed in order. Effusion of the liquid/spray adhesives from the wound should be also avoided. 
 
Gel Type Adhesives: Gel type adhesives are time-saving, and have the advantage of being already wet. 
However, have weak bulk strength. Gel type adhesives are dependent on crosslinkers for adhesion, and have 
mainly been researched for use in tissue engineering applications7, 8. 
 
Powder Type Adhesives: The powder type adhesives are easy to sterilize by UV treatment and have higher 
wettability compared to membrane type adhesives9, 10. In addition, when sustained in dried state, they are easier to 
store. However, for reaction initiation, these adhesives require a driving force such as body fluid, and too much 
body fluid may reduce bulk strength. 
 
Membrane Type Adhesives: Membrane type adhesives are easy to handle at the time of application. Time is 
saved in the pre-mixing process, and these adhesives can be stored longer than others without adhesive base 
denaturation. The membranes can be readily regulated its 3D constitution. Two 3D types are well known—mesh 
structured and pore structured (Table 1.5). 
 
Table 1.5. Spatial structure of membrane shaped materials 
Membrane Style Flat Pored Meshed
Wall Thickness Very thick Thin~Thick Thin
Pore Size Control - Easy Hard  
 
In addition, its inner connection through holes considerably improves tissue reactions compared to flat 
adhesives11-13. Nutrients and wastes can be transferred through the membrane via the holes. Importantly, cells and 
cytokines can also pass through the holes and result in the establishment of a new extracellular matrix (ECM). The 
effect of the pores has also been studied in the context of clinical applications and tissue engineering.  
 
 
1.2.2.2. Adhesive Composition 
 
Adhesive Base: The adhesive base is classified into biopolymers and synthetic polymers (Table 1.6). 
Biopolymers include proteins and polysaccharides. The proteins can be further classified into human-derived and 
other animal-14 or plant-derived. The origin of the adhesive base can influence infection, cost, and 
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biocompatibility. In an attempt to ameliorate the existing disadvantages, some polymers were blended and applied 
as an adhesive base5. 
 
Table 1.6. Adhesive bases and their origins 
Adhesive Bases Examples Immunogenicity Infection Cost Degradability
Biopolymers
Proteins
Collagen
Gelatin
Fibrin
Albumin
Keratin etc.
Low High High High
Poly
saccharides
Chitosan
Alginate
Chondroitin sulfate
Dextran aldehyde etc.
Low/Middle Low Middle Low/Middle
Synthetic 
polymer
Polyurethane
PCL
Cyanoacrylate
Dendrimer etc.
Middle/High Low Low Low
 
 
Adhesive bases derived from proteins have high affinity for human tissues15. Collagen, which is 
composed of gelatin, is the most abundant resource in our body16. Cells can react to materials such as gelatin, 
elastin, and keratin via a binding site known the Arg-Gly-Glu (RGD) structure17. Fibrin and albumin are enriched 
in blood. Fibrin mediates thrombocyte adhesion facilitating hemostat: fibrin adhesives adopt the fibrin property of 
hemostat mechanism18. Albumin is the serum derived protein and the amino groups are used for crosslinking cite.   
 
Adhesive bases derived from animals, especially from humans, show low immunogenicity, high 
biodegradability, and low inflammatory properties19, although they carry high risk of infection. In contrast to 
proteins, synthesized bases are low/not biocompatible and are immunogenic with low biodegradability; however, 
they are economical and carry a low risk of infection. Polysaccharide derivatives20, 21 show intermediate properties 
between the protein derivatives and synthetic polymers. 
 
Crosslinker: Fibrin, cyanoacrylate, aldehyde, and EDC-NHS are the chemical crosslinkers frequently used in 
medical adhesives. Genipin, derived from plants, and citric acid derived crosslinker (trisuccinimidyl citrate: TSC) 
are promising crosslinkers with high biocompatibility and great bonding strength (Table 1.7). 
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Table 1.7. Chemical crosslinkers 
Crosslinker Immuno-genicity Infection Reaction Adhesion Notes
Cyanoacrylate
High
Low Fast Strong
By-product:
formaldehyde
N-Hydroxysuccinimide(NHS)-ester 
Carbodiimide (EDC)  Low
Glutaraldehyde High By-product: Aldehyde 
Genipin
Low
Slow Under Study
Fibrin High Middle Weak 
Citric acid derived crosslinker (TSC) Low Fast Strong Commercially unavailable  
 
Cyanoacrylate and aldehyde crosslinkers including glutaraldehyde, acetaldehyde, and formaldehyde are 
effective in crosslinking, are economical, and carry low risk of infection due to their synthetic origin22. However, 
cyanoacrylate leaves formaldehyde as a byproduct, and aldehyde crosslinkers leave aldehyde as a byproduct. 
These byproducts can induce inflammation in vivo. In spite of the toxicity, these crosslinkers are often used for 
clinical operations due to their superior adhesivity.  
 
N-hydroxysuccinimide (NHS) ester and ethyl(dimethylpropyl)carbadiimide (EDC) are typically used 
simultaneously in crosslinker syntheses23. EDC shows low immunogenicity and destabilizes carboxyl groups, 
thereby improving effective NHS introduction. NHS stabilizes active esters and shows acridity owing to its 
acidity. 
  
Genipin is a plant-derived crosslinker that shows low toxicity and strong adhesion but slower 
crosslinking that can occur over three days. Furthermore, its regulation of crosslinking level is still unclear24. 
  
Fibrin is applied in practical treatment. Derived from plasma, fibrin is less immunogenic and highly 
metabolic, but can be infectious and shows low bonding strength to tissue25..  
 
 
1.2.2.3. Adhesive Conception 
 
Current studies report several adhesives bonding strongly to tissues with little to no dependence on 
chemical crosslinker. These materials can be divided into three types of adhesives: biomimetic adhesives, 
naturally derived adhesives, and nanomaterials (Figure 1.6). The driving forces behind each adhesion can be 
categorized into van der Waals’ force and hydrogen bonding between the materials and the tissues (Table 1.8). 
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Figure 1.6. Conceptions of adhesives 
 
Biomimetic Adhesives: The biomimetic adhesives include dihydroxyphenylalanine (DOPA) and Gecko’s foot, 
both of which have high adhesion ability. The adhesion mainly depend s on the morphologies of the bonds.  
 
DOPA is molecularly identical to mussel retinaculum4,26. Mussel adheres strongly to ship hulls by 
secreting adhesive substances, a property that could be attributed to its catechol molecular geometry. The 
water-resistant characteristic of DOPA has attracted much attention for its potential application to wet tissue27-29. 
 
Geckos climb walls without secreting any sticky substance from its limbs, under both wet and dry 
conditions. Besides, the stickiness is retained semi-permanently, while the stickiness of other adhesives is weaken 
owing to the condition and repeats of sticking and stripping. The adhesivity is due to its hand-like geometry at 
micro scale. The geometry imitations of the geckos foot are still under on-going research4, 30, 31.  
 
Natural Derived Adhesives: Natural resources with strong bonding properties also exist. They are different 
from biomimetic adhesives, and these natural derived adhesives are put into practice those original ingredients 
with some processing like mixing with other materials and qualifications to combine merits of the natural 
resources and the other materials. . 
  
Alginate32-34 is a component of seaweed and is widely used in medication, primarily as a hemostatic 
agent. Owing to its origin, the material shows low immunogenicity and low risk of infection. The solubility of 
original alginate is very low and it is neutralized by alkaline dosage. Therefore, alginate is used in controlled 
release medications.  
  
Dextran is a polysaccharide produced by a lactic acid bacterium. Combining it with poly (L-lysine) 
causes it to undergo the Schiff reaction and results in gelation35. Dextran shows antibacterial properties owing to 
its ionic absorption and destructive interaction with the bacterial membrane.  
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Nanomaterials: Nanosheet36-39 and Nano particles40 comprise a class called nanomaterials. Their adhesive 
ability is mainly derived from van der Waals’ forces. These materials can be fabricated from various polymers 
including artificial ones like PCL and natural ones like collagen41. Microneedle conception is a relatively new 
mechanism in which anchor the needles in tissue by needles-swelling at its stinging place4, 42. 
 
Table 1.8. Adhesives and those driving forces of tissue bonding 
Driving Force Material Examples
Van der Waals’ force
Nano Sheet
Nano Particle
Gecko’s Foot
Hydrogen bond DOPA
Interlocking Microneedle
Chemical bond Crosslinker
Hydrophobical interaction Hydrophobically modified gelatinAnchoring  
 
 
 
1.3. Hydrophobically Modified Gelatin Solution and TSC Crosslinker 
 
 
1.3.1. Hydrophobically Modified Gelatins 
 
 To develop materials with biocompatibility and strong bonding ability, hydrophobically modified 
gelatin (hm-Gltn) adhesives have been researched. The main source of gelatin is porcine skin. Gelatin is widely 
used and studied in clinical applications and is well known for its good biodegradability and lack of inflammatory 
response. The potency of hydrophobic group modification of polymers has been clarified to improve tissue 
interaction, and the hm-Gltns have been developed with a hypothesis such that combining them will result in new 
materials with superb adhesivity43-46. 
 
 
1.3.2. TSC Crosslinker 
 
The citric acid-derived crosslinker TSC was also developed in an attempt to generate a material with 
low cytotoxicity and effective crosslinking. Citric acid is abundant in our bodies and is one of main components in 
the aerobic metabolism cycle, also known as the citric acid cycle. The molecular structure of this compound 
includes three carboxyl tails that are modified with highly reactive n-hydroxysuccinimide (NHS) groups. With 
these characteristics, TSC can effectively crosslink polymers through amino groups and can be smoothly 
metabolized after adhesive biodegradation (Figure 1.7) 47. 
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Figure 1.7. Citrate derived crosslinker: TSC. 
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 Figure 1.8. Adhesion between wet tissue and original/hydrophobically-modified gelatin-‘liquid’ adhesive. 
  
Hm-Gltn ‘liquid’ adhesives crosslinked by TSC were reported to have superior bonding ability to wet 
tissue with suitable crosslinking speed and low inflammatory response in vivo. The bonding strength dependence 
on the hydrophobic group and the modification ratio are now clear. The hydrophobic interaction between hm-Gltn 
and cells or tissue combined with the anchoring effect of the hydrophobic group into lipid membranes are thought 
to be the driving forces of strong adhesion. 
 
 
 
1.4. Purpose and Objective of This Study 
 
 Fabrication of an ideal adhesive with strong bonding ability, good biocompatibility, and effectiveness in 
wound treatment requires further molecular design. Achieving adhesiveness is also necessary. However, only few 
materials currently meet these requirements. As described above, the liquid adhesive composed of hm-Gltn base 
and the TSC crosslinker is good candidate with strong bonding ability to wet tissue, and shows superb 
biocompatibilities in vitro and in vivo. 
 
Meanwhile, the bonding ability to wet tissues and other properties of the hydrophobically modified 
gelatin adhesive in film condition remains unclear. On the other hand, various studies of tissue regeneration using 
biomaterials been carried out. Cellular differentiation control by scaffold structures, angiogenesis induction by 
growth factor dosage, and material-cellular transplanting have all been examined. Therefore, further uses 
including tissue regeneration can be expected for film adhesives with previously arranged structures. 
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Given this background, the current research was focused on the bonding properties and the tissue 
reaction to ‘film’ adhesives fabricated with hm-Gltn. We investigated the hydrophobic group length effect, the 
bulk strength effect, and the special structure effect of the hm-Gltn films (Figure 1.9). 
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Figure 1.9. Adhesive elements and the candidates employed in this research. 
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Chapter 2 
 
Bonding Behavior of Hydrophobically Modified 
Gelatin Films on the Intestinal Surface 
  
 
2.1. Summary 
 
 The bonding behavior was determined for hydrophobically modified alkaline-treated gelatin on wet 
porcine intestinal surfaces. The modified gelatin films were obtained by reacting the amino groups of 
alkaline-treated gelatin with fatty acid chlorides of different alkyl chain lengths, namely, hexanoyl (Hx: C6) 
chloride, decanoyl (Dec: C10) chloride, and stearoyl (Ste: C18) chloride. Three kinds of the films were prepared, 
32HxAlGltn, 24DecAlGltn, and 26SteAlGltn that had substitution ratios of hydrophobic groups to the amino 
groups of 32HxAlGltn, 24DecAlGltn, and 26SteAlGltn of 32%, 24%, and 26%, respectively. The 32HxAlGltn 
film had the strongest bonding to porcine intestinal surfaces. A thick 32HxAlGltn film remained on the intestinal 
surface even after the bonded film was scraped off for the measurement of bonding strength. In addition, the burst 
strength increased with an increase in the substitution ratio of the Hx group. Thus, the HxAlGltn film with the 
higher Hx modification ratio has a potential as a sealant material to prevent agglutination of intestinal surfaces. 
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2.2. Introduction 
 
 Agglutination is a major obstacle in successful post-surgical wound healing. The closure of the 
wounded surface with sutures may cause inflammation and subsequent accumulation of fibrin, microphages, and 
fibroblasts, causing agglutination of the wounded surface. In extreme cases, this process can even cause intestinal 
obstruction. The agglutinated site cannot be lysed with medications; instead, it has to be treated by physical 
dissection. Various methods have been reported for preventing the occurrence of conglutination, including surgical 
techniques, pharmacological approaches, and material-based barriers1-3. Among them, material-based barriers, 
especially anticoagulation film-based barriers, have a high reliability for preventing post-surgical agglutination4-7. 
Some commercially available barrier materials include Seprafilm®8-13, Intercede®14, Repel-CV®15, Gore-Tex 
Surgical Membrane®16, and Prevadh®17. These barrier materials are normally composed of cellulose derivatives, 
hyaluronic acid, poly(ethylene glycol), poly(lactic acid), hydrophilic collagen, or polytetrafluoroethylene. An 
efficient material-based barrier should be biocompatible, anti-adhesive, and biodegradable. In addition, the film 
must adhere tightly to wet tissues to prevent film detachment from the operation site. 
Previously, we developed a liquid adhesive composed of hydrophobically modified gelatin (hm-Gltn), 
which improved the bonding ability to porcine arterial media compared with the conventional Gltn-based 
adhesives18-21. The bonding strength of the adhesive depended on the structure of the added hydrophobic 
groups22,23. It has been reported that the chain length of the adhesive can affect percutaneous absorption24. In 
addition, several ongoing studies including nanoparticle carriers have demonstrated great tissue absorbability8,25,26. 
Based on these findings, it appears that certain types of hydrophobic groups increase the bonding strength of 
adhesive materials.  
In this study, hydrophobically modified alkaline-treated gelatins (hm-AlGltns) were synthesized by 
reacting the amino group of AlGltn with fatty acid chlorides of different chain lengths, including hexanoyl (Hx: 
C6) chloride, decanoyl (Dec: C10) chloride, and stearoyl (Ste: C18) chloride. The resulting hm-AlGltns were 
molded into films, and their adhesion to wet intestinal surfaces was evaluated. 
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2.3. Materials and Methods 
 
 
2.3.1. Materials 
 
 AlGltn derived from porcine skin (beMatrix™; molecular weight 100,000) was donated by Nitta 
Gelatin Inc. (Osaka, Japan). Ethanol (EtOH), 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), dimethyl sulfoxide 
(DMSO), triethylamine (TEA), 2,4,6-trinitorobenzoylsurfonic acid (TNBS), hydrochloric acid (HCl), sodium 
dodecyl sulfate (SDS), 10% neutral-buffered formalin, and glycine were purchased from Wako Pure Chemical 
Industries, Ltd (Osaka, Japan). Hx chloride, Dec chloride, and Ste chloride were purchased from Sigma Chemical 
Co. (St Louis, MO, USA). The porcine intestine was obtained from Funakoshi Corporation (Tokyo, Japan). All 
chemicals were used without further purification. 
 
 
2.3.2. Synthesis of hm-AlGltns 
 
 Hm-AlGltns were prepared by following the procedure reported19-21. Briefly, 10 g of AlGltn was 
dissolved in 99 mL of dehydrated DMSO at 80°C. Then, 1 mL of TEA was added to the AlGltn/DMSO solution to 
produce 100 mL of 10% (w/v) AlGltn/DMSO solution under a dry nitrogen atmosphere. Subsequently, each fatty 
acid chloride (i.e. Hx, Dec, or Ste chloride) was added to the AlGltn solution, which was then stirred for 17 h at 
room temperature. The resulting hm-AlGltn/DMSO solution was added to 300 mL of cold EtOH, followed by 
stirring for 1 h. The hm-AlGltn precipitate was washed three times with 300 mL of cold EtOH to remove 
unreacted fatty acid chlorides. The hm-AlGltn was obtained under vacuum as a white precipitate. 
 
 
2.3.3. Characterization of hm-AlGltns 
 
 Light absorbance measurement can determine the amount of TNBS molecules that react with the amino 
group residues on the hm-AlGltn molecules (i.e. unsubstituted amino groups). Therefore, the modification ratios 
of the hydrophobic groups on the AlGltn molecules were quantified by using the TNBS method27. Briefly, 0.05% 
(w/v) hm-AlGltn in DMSO and AlGltn in DMSO solution were prepared. Next, 100 μL of 0.1% (w/v) 
TEA/DMSO, 50 μL of 0.1% (w/v) SDS/DMSO, and 100 μL of 0.1% (w/v) TNBS/DMSO were added to 100 μL 
of AlGltn/DMSO or hm-AlGltn/DMSO solution. The solution was incubated at 37°C for 2 h under light-shielding 
conditions, and 50 μL of 2 N HCl/DMSO was added to the solution to terminate the TNBS reaction. Finally, 
spectrophotometrical measurement of light absorbance intensity was performed on a microplate reader (GENios 
A-5082; Tecan Japan, Kanagawa, Japan) at 340 nm. Based on the intensities of hm-AlGltns, the substitution ratios 
of the amino groups with fatty acid chlorides were calculated by using the following equation (n = 3) 
Absorbance of AlGltnSubstitution ratio(%) 100 / Absorbance of AlGltn–Absorbance of hm-AlGltn
     
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The introduction of fatty acids to AlGltn was also confirmed by the spectra obtained from proton 
nuclear magnetic resonance (1H-NMR) spectroscopic (AL300; JEOL, Tokyo, Japan) and Fourier-transform 
infrared (FT-IR) spectroscopic (FTIR-8400S; Shimadzu, Kyoto, Japan) analyses. 
The thermal behavior of the hm-AlGltn solution was characterized by using differential thermal analysis 
(differential scanning colorimetry (DSC); DSC8230; Rigaku, Tokyo, Japan), where a 70% (w/v) hm-AlGltn/water 
solution was prepared and heated from 0°C to 100°C at 5°C/min under a nitrogen atmosphere (n = 3). 
 
 
2.3.4. Fabrication of hm-AlGltn Films 
 
 To fabricate hm-AlGltn films, a 10% (w/v) hm-AlGltn/HFIP solution was prepared, and 2.5 mL of the 
solution was poured into 4cm x 4cm x 0.5cm molds with a glass-bottom plate and silicon wall and dried at room 
temperature for 12 h. After that, hm-AlGltn films were obtained and then dried in vacuum at room temperature for 
2 days to remove HFIP. 
 
 
2.3.5. Measurement of Water-Contact Angles of hm-AlGltn Films 
 
 The water-contact angle of each hm-AlGltn and AlGltn film was measured with a contact angle meter 
(DM800; Kyowa Interface Science Co., Ltd., Saitama, Japan). Ultrapure water (Milli-Q, 2 mL) was deposited on 
each film, and the contact angle between the water droplet and film substrate was evaluated 5 s after sample 
mounting. Data were analyzed by the FAMAS software (Kyowa Interface Science Co., Ltd, Saitama, Japan). 
Three points per film were measured to determine the mean value of the water-contact angle (n = 3). 
 
 
2.3.6. Measurement of Bonding Strength of hm-AlGltn Films to the Intestinal Surface 
 
 Bonding strengths were measured using the apparatus shown in Figure 2.3(A). The porcine intestine 
was dissected into circular shapes with a diameter of 4 mm using a dermal punch. The inner surface of the 
dissected intestine was bonded onto the probe by using a cyanoacrylate-type adhesive or GelBoy® (LOCTITE; 
Henkel Japan, Tokyo, Japan). The hm-AlGltn films were cut into 7-mm-diameter circular forms, and each film 
sample was fixed onto a heated plate (37°C) by a piece of Scotch tape (3M, Tokyo, Japan) with a central hole of 4 
mm in diameter. The bonding strength was measured by Texture Analyzer (TA-XT2i; Stable Micro Systems, 
Surrey, UK) under the following conditions: contact time, 180 s; applied force, 20 g/mm2; and tracking speed, 10 
mm/min. Three samples per film (n = 3) were tested for determining the average bonding strength. 
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2.3.7. Measurement of Pressure Durability of hm-AlGltn Films on the Intestinal Surface 
 
 Burst testing was performed by using the American Society for Testing and Materials (ASTM) method 
(F2392-04)28. Briefly, the hm-AlGltn films were cut out into circular shapes with a diameter of 1.5 cm. The 
porcine intestine was dissected into 3.0-cm circular shapes with 3-mm central holes. The intestine sample was 
mounted between the metal components and the O-ring of the burst testing system. After that, each film sample 
was placed over the intestine, and physiological saline was induced into the system at a flow rate of 2 mL/min at 
37°C for measuring the pressure durability. 
 
 
2.3.8. Visualization of the hm-AlGltn Film–Intestine Interface 
 
 After measuring the bonding strength, all samples were fixed with 10% neutral-buffered formalin 
solution and stained with hematoxylin and eosin (H&E). The cross section of the stained interfaces was then 
inspected under a light microscope (BX51; Olympus, Tokyo, Japan). 
 
 
2.3.9. Statistical Analysis 
 
 Statistical analysis was performed using the Aspin–Welch t-test. A value of p < 0.05 was considered 
statistically significant. The data are presented as mean ± standard deviation (SD). 
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2.4. Results and Discussion 
 
2.4.1. Synthesis and Characterization of hm-AlGltns 
 
 Hm-AlGltns with various hydrophobic chain lengths were obtained via the nucleophilic reaction of the 
amino groups of AlGltn with fatty acid chlorides (Figure 2.1(a)). We used three types of fatty acid chlorides: Hx 
(C6) chloride, Dec (C10) chloride, and Ste (C18) chloride to evaluate the effect of hydrophobic chain length on the 
film adhesion to intestinal surfaces. Summarized in Table 2.1 are the characteristics of hm-AlGltns with various 
hydrophobic chain lengths. The substitution of the amino groups with fatty acid chlorides was determined by the 
spectrophotometric method using TNBS and confirmed that Hx, Dec, and Ste groups were successfully introduced 
into AlGltn molecules. The modification ratio of 32HxAlGltn, 24DecAlGltn, and 26SteAlGltn was 32%, 24%, 
and 26%, respectively. The amount of Dec chloride required for generating DecAlGltn was higher than of Hx and 
Ste for generating HxAlGltn and SteAlGltn, respectively. The introduction of an octanoyl group (C8) into gelatin 
has been reported to be slightly more difficult than that of lauryl (C12) and butyl groups (C4). 29 This result 
indicates that the reaction of fatty acid chlorides with medium-long alkyl groups is more difficult than those of 
short or long alkyl groups. Therefore, the reaction of the Dec group (C10) with the AlGltn molecules was probably 
more difficult than the reactions of the Hx (C6) and Ste (C18) groups. 
-NH2
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H2N-
O
Cl R+ -NH
-NH2
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O
+ HCl
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Figure 2.1. Preparation of hm-AlGltns with various hydrophobic groups: (a)chemical reaction between the fatty 
acid chlorides and the amino groups of AlGltn and (b) FT-IR spectra of AlGltn (blacki), 32HxAlGltn (blueii), 
24DecAlGltn (purpleiv), and 26SteAlGltn (iii). hm-AlGltn: hydrophobically modified alkaline-treated gelatin; 
FT-IR: Fourier-transform infrared. 
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Table 2.1. Hm-AlGltns with different modification ratios 
Compound Number of 
carbon 
Fatty acid chloride Modification (%) Yield (%) Td (C) 
In feed 
(mL) 
In amino groups of 
AlGltn (%) 
AlGltn – – – – – 38.7  1.2 
32HxAlGltn 6 49 30 32 93 34.2  1.8* 
24DecAlGltn 10 818 100 24 78 35.4  0.8* 
26SteAlGltn 18 330 30 26 55 36.5  0.2 
Hm-AlGltn: hydrophobically modified alkaline-treated gelatin. In Td measurements, all the measurement was 
under n = 3 condition. The asterisks mean p < 0.05 compared with 32HxAlGltn under Student’s t-test. 
 
 The thermal denaturation temperature (Td) of hm-AlGltns increased with an increase in alkyl chain 
length (Table 2.1). Thus, the aggregation of hm-AlGltn with longer alkyl groups through hydrophobic interaction 
is much easier than that of hm-AlGltn modified with shorter alkyl groups. However, the Td of AlGltn was greater 
than that of the other hm-AlGltns, indicating that the hydrogen bonding among the AlGltn molecules, without the 
loss of amino groups, was stronger than that among the hm-AlGltn molecules. 
 The 1H-NMR spectra of hm-AlGltns before and after the modification with hydrophobic groups were 
obtained by following the procedure described previously30. The peak at 1.3 ppm was assigned to the alkyl chain, 
indicating the successful introduction of the hydrophobic groups into the AlGltn molecules. The spectra displayed 
pronounced sharp peaks, especially that of 26SteAlGltn, suggesting that the longer hydrophobic chains in 
SteAlGltn were easier to be detected than the shorter chains in the other hm-AlGltns and AlGltn. 
Shown in Figure 2.1(b) are the FT-IR spectra of the hm-AlGltns. Typical peaks were found at 2357 cm1 
(C = O of long-chain fatty acids) and 2332–2323 cm1 (C–N of amino bond between fatty acids and the amino 
groups of AlGltn molecules), which were characteristic bands of hydrocarbons. 
 
 
2.4.2. Measurement of Water-Contact Angles of hm-AlGltn Films 
 
 A new wound area is usually moist with body fluids, such as blood or lymph. Thus, the films should 
have a high affinity for wet organ surfaces. In order to assess the surface wettability, the water-contact angles of 
all the hm-AlGltn films fabricated were measured. Shown in Figure 2.2 is the water-contact angle for each 
hm-AlGltn film measured 5 s after the application of a water droplet onto the film substrate at room temperature. 
The water-contact angle of the films increased with an increase in the alkyl chain length, and it was 56.8°, 56.2°, 
60.0°, and 97.5° for AlGltn, 32HxAlGltn, 24DecAlGltn, and 26SteAlGltn, respectively. In addition, the 
water-contact angle of 12HxAlGltn, 18HxAlGltn, and 36HxAlGltn was 52.9°, 55.6°, and 54.6°, respectively. The 
angle was 51.7°, 60.0°, and 53.8° for 9DecAlGltn, 24DecAlGltn, and 38DecAlGltn, respectively; and it was 78.9, 
97.5, and 104.7 for 10SteAlGltn, 26SteAlGltn, and 44SteAlGltn, respectively. Among the tested samples, 
24DecAlGltn had similar hydrophobicity to those of AlGltn and HxAlGltns; however, the hydrophobicity of 
26SteAlGltn was 1.7 times greater than that of all other samples. This result indicated that when hm-AlGltn was 
modified with shorter hydrophobic groups such as Hx and Dec, however, the hydrophobicity was not significantly 
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different from the initial value. In other words, the film surfaces obtain with enhanced hydrophobicity when 
modified with long alkyl chains. It is known that the chemicals composed of longer alkyl chains melt at higher 
temperatures than with those composed of shorter alkyl chains; and the melting temperature of hexanoic acid (or 
caproic acid, C5H11COOH), decanoic acid (or capric acid, C9H19COOH), and stearic acid (C17H35COOH) is 3C, 
31C, and 69.6C, respectively. This indicated that the Hx group on HxAlGltn molecules can easily penetrate the 
film to avoid contacting the water droplet at 37C, which is above its melting temperature. In contrast, the Dec or 
Ste groups on the hm-AlGltn molecules rarely moved at the same temperature, due to their relatively high melting 
temperatures. However, due to low surface tension, long hydrophobic chain–modified gelatins tend to be more 
hydrophobic, as compared with short chain–modified gelatins29,31,32. In this study, HxAlGltn with short 
hydrophobic chains had lower hydrophobicity compared with other samples, due to its high surface tension; it also 
had greater wettability than DecAlGltn and SteAlGltn. 
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Figure 2.2. Measurement of water-contact angles of AlGltn, HxAlGltns with various introduction ratios, 
24DecAlGltn, and 26SteAlGltn films. Data are presented as mean ± SD of three samples, n = 3 (*p < 0.05, **p  
0.05). AlGltn: alkaline-treated gelatin; SD: standard deviation. 
 
 
2.4.3. Bonding Behavior of hm-AlGltn Films onto the Intestinal Surface 
 
The bonding strengths of all hm-AlGltn films were comparable to or greater than that of 
the original AlGltn film (Figure 2.3(B)). In particular, the bonding strength of 32HxAlGltn film was 
approximately 1.4 times greater than that of the original AlGltn film. The 24DecAlGltn and 
26SteAlGltn films exhibited similar bonding strengths to that of the original AlGltn film. After the 
measurements, the interfaces between the films and intestinal surfaces were stained with H&E 
and visualized for evaluating the bonding or delamination of the hm-AlGltn films. The thickness of 
AlGltn, 32HxAlGltn, 24DecAlGltn, 26SteAlGltn, and TachoSil films was 9.4, 30.6, 15.6, 3.1, and 
6.3m, respectively. Among them, the comparatively thick 32HxAlGltn film remained on the 
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intestinal surface (Figure 2.3(C) (b)); in contrast, only thin layers of 24DecAlGltn and 26SteAlGltn 
films were observed after the tests (Figure 2.3(C) (c, d)). Moreover, the thickness of the remaining 
AlGltn film was between that of the thin 24DecAlGltn and 26SteAlGltn films and the thick 
32HxAlGltn film (Figure 2.3(C) (a)). These results suggested that the 32HxAlGltn film had the 
highest bonding strength to the intestinal surface among all tested films.  
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Figure 2.3. Evaluation of bonding behaviors of the hm-AlGltn films to the porcine intestine surface: (A) 
schematic illustration of the apparatus used for bonding strength measurement and (B) bonding strengths of 
hm-AlGltns to the porcine intestinal surfaces. Data are presented as mean  SD of three samples; n = 3 (*p < 0.05, 
**p  0.05). (C) Histological visualization of the film–intestine interface stained with HE after the measurement 
of bonding strength. Black arrows indicate (a) AlGltn, (b) 32HxAlGltn, (c) 24DecAlGltn, (d) 26SteAlGltn, and (e) 
TachoSil layers that remained on the intestinal surfaces (scale bar = 50 m). hm-AlGltn: hydrophobically 
modified alkaline-treated gelatin; SD: standard deviation. 
 
The tensile strengths of the hm-AlGltn films were measured (data not shown) to characterize the 
bonding behavior of the hm-AlGltn films to intestinal surfaces. The 26SteAlGltn film had the highest tensile 
strength among all the hm-AlGltn films, probably because the Ste hydrophobic group induced significantly more 
physical cross-linking in the film. In other words, long alkyl chains could enhance the mechanical strength of the 
hm-AlGltn films, although they did not promote the interpenetration between the films and intestinal surface 
layers. The stronger mechanical strength of 26SteAlGltn may result in weaker bonding to the intestinal surface, 
compared to other films; because rigid materials cannot maintain a conformable attachment to the large surface 
area of the adherent, this results in dramatically reduced adhering or bonding behaviors. On the other hand, soft 
materials are capable of creating stronger bonding as compared with rigid materials. In this study, the 32HxAlGltn 
Bonding Behavior of Hydrophobically Modified Gelatin Films on the Intestinal Surface 
25 
film, which exhibited similar mechanical strength to that of blood vessels, had significantly greater bonding 
strength to the intestinal surfaces compared with other films. 
 
 
2.4.4. Pressure Durability of hm-AlGltn Films on the Intestinal Surface 
 
 As body fluids and digested food materials flow through the intestines, the hm-AlGltn films should be 
able to sustain external pressure to maintain their intactness. A burst test was performed to investigate the pressure 
durability of the prepared films (Figure 2.4(A)). Shown in Figure 2.4(B) is the effect of the Hx modification ratio 
on the burst strength, and the HxAlGltn films with low modification ratios had lower burst strengths compared 
with those with high modification ratios. 
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Figure 2.4. Durability test of the HxAlGltn films on the intestinal surfaces against saline-flow pressure. (A) The 
overall view of the (a) burst test system and (b) film-mounting device. (B) Comparison of the burst durability of 
the HxAlGltn films (●) and TachoSil () on the intestinal surface. Data are presented as mean  SD of three 
samples; n = 3 (*p < 0.05, **p  0.05). hm-AlGltn: hydrophobically modified alkaline-treated gelatin; SD: 
standard deviation. 
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The hydrophobic groups introduced into the AlGltn molecules can promote the penetration of 
hm-AlGltn in the intestinal serosa (Figure 2.3). In particular, the Hx group demonstrated the most effective 
interpenetration among all the reaction groups. Dec and Ste groups have longer hydrophobic chains than the 
Hx group and induced severe hydrophobic aggregation of the hm-AlGltn molecules in the films. Moreover, 
the melting temperature of the hydrophobic groups is an important determinant of the ability of hm-AlGltn to 
penetrate the intestinal surface. Since hexanoic acid has the lowest melting temperature among hexanoic acid, 
decanoic acid, and stearic acid, Hx may have higher mobility and interact more easily with the intestine at 
physiological temperature (37C) as compared with other hydrophobic groups (Figure 2.5). 
Histologically, the surface layer of the intestine is composed of extracellular matrix proteins, including 
elastin and type IV collagen. Collagen is one of the most abundant components in all organs and presents in a 
triple helix in its natural state19. AlGltn can be obtained by the denaturation of collagen molecules. Therefore, the 
formation of partial triple helices with hm-AlGltn and collagen molecules of the intestinal tissues, in addition to 
the interpenetration between the hydrophobic groups and intestinal surface, is highly probable. Furthermore, the 
hydrophobic groups of hm-AlGltn may interact with the hydrophobic amino acids or cellular phospholipid 
bilayers in the intestinal tissues33. These components also contribute to the enhanced bonding strength of the 
hm-AlGltn film to the intestinal surface, as compared with the bonding of original AlGltn film. 
Agglutination can occur not only to the intestinal surfaces but also to other organs in the human body. 
Agglutination is a complicated process that includes inflammatory reactions between inflamed and healthy organs after 
contact. To avoid possible contact between the inflamed tissues around the wounded site and other healthy tissues or 
organs, anti-adhesive materials are widely used in clinical surgeries. The adhesive bonding of the film material to the 
wounded site provides an effective solution for preventing the direct contact with unaffected sites; however, frequent 
delamination and detachment of the anti-adhesive films are the major obstacles for their effective usage. The bonding 
abilities of the hm-AlGltn films prepared in this study to the porcine aorta were tested (data not shown), and they had 
enhanced bonding behaviors compared with conventional films. HxAlGltn film had stronger bonding to the aorta as 
compared with DecAlGltn and SteAlGltn films, and the increase in the bonding strength of various HxAlGltn films was 
in accordance to their Hx group introduction ratio. In this study, the bonding behaviors of the films to the intestinal 
surfaces were investigated, and the evaluation of their bonding strengths to other organs, including the uterus and liver, 
will be conducted in the future. 
Increased bulk strength is required to obtain hm-AlGltn films with high bonding strengths without 
compromising the mobility of hm-AlGltn. Although the hm-AlGltn films prepared in this study were fabricated by 
using the solvent-evaporation method, it has been suggested that the optimum cross-linking of the hm-AlGltn films with 
some biocompatible cross-linkers34–36 or heat treatment could increase both the bonding and bulk strengths30. 
Ideally, the anti-adhesive films should gradually degrade with the progression of the wound healing process. 
Thus, the biodegradability of the 25HxAlGltn film formed by the citrate acid–derived cross-linker in rat subcutaneous 
tissues was tested in a previous study, and it was found that the film completely degraded within 28 days (data not 
shown). Therefore, we assumed that this degradation period could be controlled by the cross-link density and 
hydrophobicity of the hm-AlGltn films. 
The bonding of anti-adhesive materials has been reported to not only prevent agglutination but also promote 
the cellular activities through cellular adhesion in in vitro studies37–39. This indicated that the hm-AlGltn films have 
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great promise for use not only as clinical anti-adhesive materials but also as scaffold substrates for cellular 
functionalization. 
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Figure 2.5. Schematic representation of the bonding behaviors of the hm-AlGltns films containing various 
hydrophobic groups to the intestinal surfaces (AlGltn: C0; 32HxAlGltn:C6; 24DecAlGltn: C10; and 26SteAlGltn: 
C18). hm-AlGltn: hydrophobically modified alkaline-treated gelatin. 
 
 
2.5. Conclusion 
 
 In this study, the bonding behavior of hm-AlGltn films onto the porcine intestinal surface was 
investigated for post-surgical wound healing. The HxAlGltn film had higher bonding strength onto the intestinal 
surface compared to DecAlGltn and SteAlGltn films. A thick HxAlGltn film remained at the bonding interface, 
whereas only thin layers of the DecAlGltn and SteAlGltn films remained on the intestinal surface after the 
measurement of their bonding strengths. The burst strength of HxAlGltn on the intestinal surface increased with 
the increase in the Hx modification ratio. These results indicated that the hm-AlGltn films could be used as potent 
anti-adhesive materials for preventing organ agglutination after clinical surgeries. 
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Chapter 3 
 
Enhanced Bonding Strength of Hydrophobically 
Modified Gelatin Films on Wet Blood Vessels 
  
 
3.1. Summary 
 
 The bonding behavior between hydrophobically modified alkaline-treated gelatin (hm-AlGltn) films and 
porcine blood vessels was evaluated under wet conditions. Hexanoyl (Hx: C6), decanoyl (Dec: C10), and stearyl 
(Ste: C18) chlorides were introduced into the amino groups of AlGltn to obtain HxAlGltn, DecAlGltn, and 
SteAlGltn, respectively, with various modification percentages. The hm-AlGltn was fabricated into films and 
thermally crosslinked to obtain water-insoluble films (t-hm-AlGltn). The 42% modified t-HxAlGltn 
(t-42HxAlGltn) possessed higher wettability than the 38% modified t-DecAlGltn (t-38DecAlGltn) and the 44% 
modified t-SteAlGltn (t-44SteAlGltn) films, and the t-42HxAlGltn film showed a high bonding strength with the 
blood vessel compared with all the hm-AlGltn films. Histological observations indicated that t-42HxAlGltn and 
t-38DecAlGltn remained on the blood vessel even after the bonding strength measurements. From cell culture 
experiments, the t-42HxAlGltn films showed significant cell adhesion compared to other films. These findings 
indicate that the Hx group easily interpenetrated the surface of blood vessels and effectively enhanced the bonding 
strength between the films and the tissue. 
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3.2. Introduction 
 
 Wound closure is one of the fundamental requirements in surgical operations. A suture is usually 
employed to close the wounded region. However, the use of sutures prolongs operation time and is not suitable for 
some complicated areas such as the junction site of a blood vessel and a lung. Therefore, tissue adhesives have 
been developed and used in the clinical field for shortening the operation time and for the closure of wounds with 
complicated structures1. However, these adhesives still possess some disadvantages in terms of bonding strength 
and biocompatibility2–11. For example, TachoSil® (CSL Behring K.K., Tokyo, Japan) is a common clinically 
available adhesive composed of equine collagen and fibrin; it, however, has several shortcomings. Xenogeneic 
product collagen and allogeneic fibrin may result in infection, and the fibrin-induced adhesivity is not very strong. 
Especially in terms of bonding strength, adhesives bonded on soft tissues are exposed to adverse environments 
because about 70% of our body is made of water. In addition, body fluids such as blood plasma and lymph fluid 
spill out from the wound area after a surgical operation. 
To overcome these obstacles, molecular design of tissue adhesive materials that show good bonding 
behavior even on moisture-containing tissues is required. We recently developed a hydrophobically modified 
gelatin (hm-Gltn)-based adhesive and showed that the resulting hm-Gltn adhesive with a low modification 
percentage formed a stronger bond on porcine arterial media as compared to the original Gltn-based adhesives12–16. 
Our results suggest that films composed of hm-Gltn have the ability to bond to soft tissues even under wet 
conditions. However, the detailed adhesive properties of these hm-Gltn films have not yet been clarified. 
For this purpose, hydrophobically modified alkali-treated Gltns (hm-AlGltns) were prepared by the 
modification of the amino groups of AlGltn with fatty acid chlorides with various chain lengths, including 
hexanoyl (Hx: C6) chloride, decanoyl (Dec: C10) chloride, and stearyl (Ste: C18) chloride. We selected those fatty 
acid chlorides because our previous research showed that a longer hydrophobic group such as Ste resulted in good 
adhesivity to tunica media 13,15. Therefore, the longest fatty acid is Ste in this research, and together we used a 
tunica blood vessel as an adherend, so, the fatty acid chlorides with different chain lengths could be compared 
with Ste. The obtained hm-AlGltns with various modification percentages were cast to fabricate films; these were 
then thermally crosslinked to prepare water-insoluble hm-AlGltn (t-hm-AlGltn) films. Using the t-hm-AlGltn 
films, surface wettability and bonding behavior on porcine blood vessels were evaluated. 
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3.3. Materials and Methods 
 
 
3.3.1. Materials 
 
 BeMatrix™, an alkaline-treated gelatin (AlGltn) derived from porcine skin, was kindly donated by Nitta 
Gelatin Inc. (Osaka, Japan). Ethanol (EtOH), 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), dimethylsulfoxide 
(DMSO), triethylamine (TEA), 2,4,6-trinitrobenzoylsulfonic acid (TNBS), hydrochloric acid (HCl), sodium 
dodecyl sulfide (SDS), calcium chloride, 10% formalin neutral buffer solution, 4’,6-diamidino-2-phenylindole 
(DAPI), tris(hydroxymethyl)aminomethane, tert-butylalcohol, and glycine were purchased from Wako Pure 
Chemical Industries, Ltd. (Osaka, Japan). Hexanoyl (Hx: C6) chloride, decanoyl (Dec: C10) chloride, and stearyl 
(Ste: C18) chloride were purchased from Sigma Chemical Co. (St. Louis, MO, USA). A porcine aorta was 
purchased from Funakoshi Corporation (Tokyo, Japan). RPMI was purchased from Lonza ((Basel, Switzerland)). 
L929 cells were purchased from RIKEN (Bio Resource Center Cell Bank, RBRC-RCB2619, Ibaraki, Japan). All 
chemicals were used without further purification. 
 
 
3.3.2. Synthesis of hm-AlGltns 
 
 Based on former reports13–16, hm-AlGltns with various chain lengths and densities were prepared by the 
reaction between fatty acid chlorides and primary amino groups of AlGltn. The employed fatty acid chlorides 
were hexanoyl (Hx: C6), decanoyl (Dec: C10), and stearyl (Ste: C18) chloride. First, AlGltn (10 g) was fully 
dissolved into 99 mL of dried DMSO at 80 °C. Then, one mL of TEA was added into the AlGltn/DMSO solution 
to obtain 100 mL of 10 w/v% AlGltn/DMSO solution under a dry N2 atmosphere. The fatty acid chloride was 
subsequently added to the AlGltn solution and stirred for 17h at room temperature. The resulting 
hm-AlGltn/DMSO solution was then poured into 300 mL of cold EtOH and stirred for 1h. Subsequently, the 
precipitate of hm-AlGltn was washed twice with 300 mL of cold EtOH followed by evaporation under vacuum to 
leave a white cake of which the yield was calculated. 
 
 
3.3.3. Characterization of hm-AlGltns 
 
 The modification percentages of the hydrophobic groups in AlGltn were quantified by the method 
previously reported using TNBS13–17. Briefly, each hm-AlGltn and the original AlGltn were dissolved in DMSO to 
obtain 0.05 w/v% solutions. Then, 100 μL of 0.1v/v% TEA/DMSO, 50 μL of 0.1 w/v% SDS/DMSO, and 100 μL 
of 0.1w/v% TNBS/DMSO were added to 100 μL of each (hm-) AlGltn/DMSO solution, followed by incubation at 
37 °C for 2h under light-shielding conditions. Then, 50 μL of the 2 N-HCl/DMSO solution was added to stop the 
reaction. Finally, the intensity of light absorbance was measured spectrophotometrically at 340 nm using a 
microplate reader (GENios A-5082, Tecan Japan, Kanagawa, Japan). The substitution percentage of amino groups 
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with the fatty acid chlorides was then calculated from the intensities of hm-AlGltn compared with the original 
AlGltn. 
The modification of the fatty acid in AlGltn was confirmed by 1H-NMR (AL300, JEOL, Tokyo, Japan) 
and FT-IR (FTIR-8400S, Shimadzu, Kyoto, Japan) measurements. The typical peaks were found at 2357 cm−1 
(C=O bond of long-chain fatty acids) and 2332–2323 cm−1 (C–N bond of amino bonding between fatty acids and 
the amino groups of the AlGltn molecules). 
Thermogravimetry (TG) analysis was executed to analyze thermal behavior of obtained hm-AlGltns 
(TG8120, Rigaku, Tokyo, Japan). Heating was conducted from 30 to 300 °C at a heating rate of 10 °C/min. 
Aluminium oxide was employed as control.The thermal behavior of the hm-AlGltn solution was also analyzed by 
differential thermal analysis (DSC) (DSC8230, Rigaku, Tokyo, Japan). The hm-AlGltns were dissolved in 
ultrapure water (Merck Millipore, Tokyo, Japan) to prepare 70 w/v% samples. Heating was conducted from 0 to 
100 °C at a heating rate of 5 °C/min under nitrogen atmosphere.  
 
 
3.3.4. Preparation and Characterization of Thermally Crosslinked hm-AlGltn Films 
 
 Each hm-AlGltn was first dissolved in HFIP to prepare a 10w/v% solution. Each solution (2.5 mL) was 
then cast on a 4 × 4 × 0.5 cm3 mold with a glass plate bottom and a silicone wall and was dried for 12h, followed 
by drying overnight under vacuum at room temperature. The resulting films were placed between two thin silicone 
sheets and sandwiched between metal plates. Thermal treatment was then performed under vacuum at 140 °C for 
24h. 
In order to determine the residual amino group amount in t-hm-AlGltn, each film was cut into a disk 
4mm in diameter and then immersed in 300 μL of ultrapure water. Then, 300 μL of a 4 w/v% NaHCO3 aqueous 
solution and 300 μL of a 0.1 w/v% TNBS aqueous solution were added. After incubation for 2h, 600 μL of 6 
N-HCl was added to stop the reaction. Then, 300 μL of each sample was placed into each well of a 96-well plate 
and the absorbance was measured at 340 nm using a microplate reader (GENios A-5082, Tecan Japan, Kanagawa, 
Japan).  
 
 
3.3.5. Measurement of Water Content of Thermally Crosslinked hm-AlGltn Films 
 
 The thermally crosslinked hm-AlGltn films were cut into disks 4mm in diameter and were immersed in 
1μL of ultrapure water at 37 °C. The weights of the swollen films after various time periods were gravimetrically 
determined. The water content of the films was calculated using the following equation:  
 
Water content (%) = (W'- W)/W' x 100 …(1) 
(W': weight of swollen film, W: weight of dried film.) 
 
The water contents of the films after 5 min immersion in water were compared. 
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3.3.6. Determination of Surface Wettability of Thermally Crosslinked hm-AlGltn Films 
  
In order to determine the surface wettability of the thermally crosslinked hm-AlGltn films, the water 
contact angle of each film was measured using a contact angle meter (DM800, Kyowa Interface Science Co., Ltd., 
Saitama, Japan). Briefly, 2 μL of ultrapure water was placed on the t-hm-AlGltn films and the time dependent 
change in the static water contact angle was measured after 3, 10, 30, 60, 120 and 180s. The resulting data were 
analyzed using FAMAS software (Kyowa Interface Science Co., Ltd., Saitama, Japan). 
 
 
3.3.7. Measurement of the Mechanical Strength of Thermally Crosslinked hm-AlGltn Films 
 
 Each film was cut out into 5 mm × 1 cm rectangular shapes and both sides were bonded on 5 mm × 1 
cm plastic sheets by GelBoy (LOCTITE, Henkel Japan, Tokyo, Japan) in a 2.5 mm × 5 mm area. After drying at 
room temperature, the plastic sites were clipped to probes and tensile tests were performed for all samples before 
and after thermal crosslinking at a rate of 10 mm/min (n = 3). 
 
 
3.3.8. Measurement of Bonding Strength between Thermally Crosslinked hm-AlGltn Films and 
Blood Vessel 
 
 There was no existing protocol in place to evaluate the bonding strength between the tissue surface and 
the film; therefore, the following measurement method was applied. The porcine blood vessel was dissected with 
a dermal punch into disks 4mm in diameter. The dissected blood vessel was bonded onto a probe with GelBoy. 
The t-hm-AlGltn films were also punched out into 7 mm diameter disks and placed on a heated plate at 37 °C. 
They were fixed to the heated plate with scotch tape (3M, Tokyo, Japan) with a hole 4 mm in diameter. The 
bonding strength was then measured using a Texture Analyzer (TA-XT2i, Stable Micro Systems, Godalming, UK) 
(n = 3) with the following conditions: 180s contact time, 20 g/mm2 applied force, and 10 mm/min tracking speed.  
 
 
3.3.9. Observation of Thermally Crosslinked hm-AlGltn Film–Blood Vessel Interfaces 
 
 After the bonding strength measurement, each sample was fixed with a 10% formalin neutral buffer 
solution followed by hematoxylin and eosin (HE) staining. Cross sections of the stained samples were observed 
with an optical microscope (BX51, Olympus, Tokyo, Japan). 
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3.3.10. Cell Adhesion onto Thermally Crosslinked hm-AlGltn Film 
 
 A mouse fibroblast cell line, L929, was used to evaluate cell adhesion onto the t-hm-AlGltn films. The 
L929s were first cultured in a medium (RPMI-1640 (R8758, Sigma-Aldrich, St. Louis, MO, USA)) containing 2 
v/v% fetal bovine serum. The t-hm-AlGltn films were placed on 24-well plates and a glass ring was put on each 
film. L929 cells (5.0 × 104 cells) were seeded onto each film for 5min and the films were rinsed with 2 mL of 
phosphate buffered saline (PBS, pH 7.4). Then the cells were fixed with 10% formalin neutral buffer solution for 
60min and permeabilized in 0.2 v/v% Triton-X 100 in PBS for 2 min followed by 0.1% DAPI in PBS for 10 min 
in light-shielding conditions at room temperature. The adhered cells were observed with an IX81 inverted 
fluorescence microscope (Olympus Co. Ltd., Tokyo, Japan). The counted number of adhered cells was calculated 
from the area of the microscopic field (n = 3).The cells were then observed with a scanning electron microscope 
(SEM). In brief, the cells were gradually dehydrated with a 50–99 v/v% ethanol/water solution. Then, the cells 
were immersed in tert-butylalcohol twice followed by freeze drying at −80 °C. The cells were then observed by 
SEM.  
 
 
3.3.11. Statistical Analysis 
 
 Statistical analysis was carried out using Student’s t-test with Microsoft Excel software. Statistically 
significant differences were accepted when p < 0.05. The data are shown as mean ± standard deviation (S.D.). 
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3.4. Results and Discussion 
 
3.4.1. Synthesis and Characterization of hm-AlGltns 
 
 As shown in Figure 3.1A, three different fatty acid chlorides, hexanoyl (Hx) chloride, decanoyl (Dec) 
chloride, and stearyl (Ste) chloride, were reacted with the amino groups of the AlGltn molecules by nucleophilic 
reactions to obtain HxAlGltn, DecAlGltn, and SteAlGltn. 
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Figure 3.1. Modification of alkaline-treated gelatin (AlGltns) with hydrophobic groups using fatty acid chlorides 
and verification of the introduction. (A) Chemical formulas of fatty acid chlorides; and (B) nucleophilic 
substitution reaction between an amino group of the AlGltn molecule and a fatty acid chloride; (C) H1-NMR 
spectra of (a) AlGltn; (b) 42HxAlGltn; (c) 38DecAlGltn; and (d) 44SteAlGltn (the arrow indicates the peak 
derived for the methyl group of the alkyl chains); (D) Weight loss of hydrophobically modified alkaline-treated 
gelatin films (hm-AlGltns). Data are shown as the average ± S.D. of three samples (* p < 0.05). 
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Table 3.1 notes the characteristics of the hm-AlGltns after the nucleophilic substitution reactions of the 
amino groups of AlGltn with the fatty acid chlorides. The substituted quantities of amino groups with fatty acid 
chlorides were determined by the 2,4,6-trinitrobenzenesulfonic acid (TNBS) method13–17. Through this reaction, 
each hydrophobic group (Hx, Dec, Ste) was successfully introduced into each AlGltn with amide bonds to form 
hm-AlGltns, whose modification percentages ranged from 10% to 44%. Table 3.1 also lists the independent 
thermal denaturation temperature (Td) of each hm-AlGltn. The value of Td of the 30% hm-AlGltns was lower than 
that of both the 10% and 40% hm-AlGltns. In addition, the hm-AlGltns with longer side chains exhibited a lower 
Td. The result may indicate that interaction between and coagulation of the introduced hydrophobic side chains 
together with the modest introduction ratio for crystallization, affected each Td. 
 
Table 3.1. Hydrophobically modified alkaline-treated gelatin films (hm-AlGltns) with various modification ratios 
Abbreviation
Number
of 
carbons
Fatty acid chloride
Modification
(%)
Yield
(%)
Td(ºC)in feed(L)
in amino groups of 
AlGltn
(%)
12HxAlGltn 6 16 10 12 91 36.2
32HxAlGltn 6 49 30 32 93 34.2
42HxAlGltn 6 82 50 42 95 36.5
10DecAlGltn 10 409 50 10 76 36.8
24DecAlGltn 10 818 100 24 78 35.4
38DecAlGltn 10 409 50 38 89 36.9
10SteAlGltn 18 110 10 10 85 37.1
26SteAlGltn 18 330 30 26 55 36.5
44SteAlGltn 18 550 50 44 91 39.6
The prefixes of the abbreviations indicate the substituted ratio of amino group of AlGltn
molecule and the introduced Hx, Dec, or Ste group (12HxAlGltn means 12 % Hx group
introduced hm-AlGltn).  
Figure 3.1(C) shows the 1H-NMR spectra of the hydrophobic group of the molecule on the AlGltn or 
hm-AlGltns. The peak of the alkyl chain appears at 1.3ppm. The peak intensities of the original AlGltn, 32HxAltn, 
24DecAlGltn, and 26SteAlGltn at 1.3 ppm were 0.14, 1.48, 1.98, and 1.69. Therefore, each hydrophobic group 
was successfully introduced into each hm-AlGltn. On the other hand, the hm-AlGltns with longer side chains 
showed sharper 1H-NMR peaks. 
The hydrated carbons of the longer side chains were easily detectable. Therefore, the 44SteAlGltn 
showed the sharpest peak as compared with other hm-AlGltns. 
Weight losses of AlGltn, 42HxAlGltn, 38DecAlGltn, and 44SteAlGltn under heating from 25–300 °C 
were compared in Figure 3.1(D). 42HxAlGltn showed the highest weight loss from 35 to 115°C indicating that 
there is more bound water in 42HxAlGltn than AlGltn, 38DecAlGltn, and 44SteAlGltn. The higher weight loss 
means a looser network structure, each (hm-)AlGltn resulting from the AlGltn molecule of (hm-)AlGltn has 
higher flexibility. 
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3.4.2. Preparation and Characterization of Thermally Crosslinked hm-AlGltn Films 
 
 Ten w/v% hm-AlGltn/HFIP solutions were cast and transparent hm-AlGltn films were fabricated. The 
films were subsequently heated at 140 °C in vacuo for thermal crosslinking. It is known that covalent amide 
crosslinks form between amino groups and carboxyl groups in Gltn molecules after thermal treatment of the 
gelatin membranes in vacuo18–20, resulting in water-insoluble Gltn films. To evaluate the amino group amounts 
used for the thermal crosslinking, the 2,4,6-trinitrobenzenesulfonic acid (TNBS) method was employed and the 
results are given in Table 3.2. The hm-AlGltns with short side chains, such as 12HxAlGltn and 10DecAlGltn, 
consumed more amino groups than the original AlGltn during the thermal-crosslinking. The hm-AlGltns with 
dense and long side chains consumed fewer amino groups. 
These results indicate that shorter side chains did not inhibit amide bond formation among the 
hm-AlGltns, whereas dense and longer side chains did because the amino group and carboxyl group on a Gltn 
molecule of an hm-AlGltn cannot exist owing to volume exclusion by inactive long side chains. 
 
Table 3.2. T-hm-AlGltns with various modification percentages. 
Abbreviation Numberof carbons
Amino groups used
for thermal crosslinking
(%)
Stiffness 
in dried state
(MPa)
t-AlGltn 0 14.9±6.3 4.66±0.22
t-12HxAlGltn 6 30.7±5.9 5.39±0.05
t-32HxAlGltn 6 11.0±4.9 4.39±0.20
t-42HxAlGltn 6 10.1±1.9 3.68±0.60
t-10DecAlGltn 10 20.0±2.6 5.06±0.11
t-24DecAlGltn 10 3.5±0.5 4.24±0.29
t-38DecAlGltn 10 0.2±2.0 3.06±0.06
t-10SteAlGltn 18 2.9±0.9 4.01±0.11
t-26SteAlGltn 18 7.2±0.1 3.49±0.42
t-44SteAlGltn 18 3.5±1.4 2.19±0.24  
 
 
3.4.3. Mechanical Strength of Thermally Crosslinked hm-AlGltn Films 
 
As shown in Table 3.2, the mechanical strength of the t-hm-AlGltns decreased with increasing 
modification percentage. Among t-hm-AlGltns with similar modification percentages but different alkyl chain 
lengths, the mechanical strength of films with longer side chains decreased. However, the t-12HxAlGltn and 
t-9DecAlGltn films were both stronger than the original t-AlGltn film. 
It is hypothesized that with thermal crosslinking, the hm-AlGltn films acquired amide bonding between 
each hm-AlGltn molecule, thus becoming resistant to hydrolysis, even though dense hydrophobic groups inhibit 
the accessibility of the amino groups to the carboxyl groups of each hm-AlGltn molecule by volume exclusion. 
Amide bonds are more difficult to form in hm-AlGltns with dense hydrophobic groups than in hm-AlGltns with 
sparse hydrophobic groups. 
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These results are due to the fact that long hydrophobic groups inhibit the approach of amino groups to 
carboxyl groups, resulting in decreased crosslinking density in the t-hm-AlGltn films. As compared to the original 
AlGltn, hm-AlGltn molecules with low modification percentages can easily assemble by hydrophobic interaction. 
Therefore, the t-12HxAlGltn and t-9DecAlGltn films showed high stiffness as compared to the t-AlGltn film.  
 
 
3.4.4. Water Content of Thermally Crosslinked hm-AlGltn Films 
 
 Figure 3.2 shows the water content of each t-hm-AlGltn film after 5min water immersion, at which 
point all the films reached a plateau. The water content of the films with dense side chains was lower compared to 
films with sparse side chains. On the other hand, the films with longer side chains showed higher water content 
compared to films with shorter side chains. The water content in t-9DecAlGltn and t-10SteAlGltn was high 
compared to the original t-AlGltn film. In all the prepared t-hm-AlGltn films, t-42HxAlGltn possessed the lowest 
water content. These results indicate that long hydrophobic groups prevented the agglomeration of Gltn molecules 
due to volume exclusion, resulting in greater retention of water molecules. In contrast, the higher mobility of short 
hydrophobic groups promoted the agglomeration of Gltn molecules, leaving less room for water molecules in the 
film. 
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Figure 3.2. Water content of t-hm-AlGltn films after immersion in water at 37 °C for 5 min. Data are shown as 
the average ± S.D. of three samples (* p < 0.05, ** p ≥ 0.05). 
 
 
3.4.5. Surface Wettability of Thermally Crosslinked hm-AlGltn Films 
 
Enhanced Bonding Strength of Hydrophobically Modified Gelatin Films on Wet Blood Vessels 
41 
 When a film is applied for surgical use to close areas on organs, such areas will be in a wet condition 
because body fluids such as blood or lymph fluids ooze from the wound. Therefore, the films need to possess a 
high affinity for wet organ surfaces for use in surgical applications. 
For the evaluation of wettability of t-hm-AlGltn films, the time dependence of the water contact angle 
was compared. In this experiment, films whose modification percentages were approximately 40%, i.e., 
t-42HxAlGltn, t-38DecAlGltn, and t-44SteAlGltn, were used. As can be seen from Figure 3.3, the water contact 
angles of the samples decreased with time. Additionally each film shows independent wettability indicating that 
t-42HxAlGltn showed excellent wettability even though the amino groups of AlGltn were partially substituted by 
Hx. However, the wettability of t-38DecAlGltn and t-44SteAlGltn was quite low compared to t-AlGltn and 
t-42HxAlGltn. 
Hx, the shortest chain possessing a low melting point of −3 °C, can move freely at 37 °C. Therefore, Hx 
can move more easily from the outside to the inside of the films to escape from the aqueous surface than can 
longer hydrophobic groups such as Dec and Ste, whose melting points are 31 °C and 69.6 °C, respectively. 
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Figure 3.3. Surface wettability of t-hm-AlGltn films. Transition of static water contact angle on t-hm-AlGltn films 
(t-42HxAlGltn, t-38DecAlGltn, t-44SteAlGltn, and t-AlGltn). Data are shown as the average ± S.D. of three 
samples (* p < 0.05, ** p ≥ 0.05). 
 
 
3.4.6. Bonding Behavior of Thermally Crosslinked hm-AlGltn Films on the Porcine Blood Vessel 
 
 The bonding strength between the porcine blood vessel and t-hm-AlGltn films with various 
modification percentages is shown in Figure 3.4A. The bonding strength of all the t-hm-AlGltn films increased 
after the modification of the hydrophobic groups compared to the original t-AlGltn. In the case of the t-HxAlGltn 
films, the bonding strength increased with increasing modification percentage. The t-32HxAlGltn and 
t-42HxAlGltn films in particular had bond strengths that were 2.5 times greater than that of the t-AlGltn film. The 
modification percentages of t-DecAlGltn and t-SteAlGltn did not show sufficient enhancement of bond strength 
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even though their bonding strengths were greater than that of the t-AlGltn film. This result indicates that the Hx 
group is the most effective side chain for blood vessel adhesion among the three hydrophobic groups, Hx, Dec, 
and Ste. The Hx group could easily interpenetrate the hydrophobic region of the extracellular matrix (ECM) or the 
hydrophobic amino acid and cell membrane of the tissue because of its low melting point, resulting in its higher 
mobility. This interpenetration of Hx contributed to the high bonding strength of t-42HxAlGltn to the porcine 
blood vessel. Furthermore, Gltn molecules in t-42HxAlGln have the ability to partially form a triple helix with the 
Gltn molecule collagen on the surface of the blood vessel. 
After measurement of the bonding strength, all of the tissue-film interfaces were fixed and hematoxylin 
and eosin (HE) staining was applied to observe the bonding/destruction behavior of the t-hm-AlGltn films on 
porcine blood vessels. By HE staining, the film remaining on the tissue surface and the tissue itself were colored 
dark purple and pink, respectively. Figure 3.4Ba and d show that no t-AlGltn or t-44SteAlGltn film remained on 
the blood vessel surfaces. However, the t-42HxAlGltn and t-38DecAlGltn films (Figure 3.4Bc and d), indicated 
by red arrows and dashed rectangles) clearly remained after the bonding strength measurement. Additionally, the 
remaining t-42HxAlGltn was thicker and broader than the t-38DecAlGltn, indicating the higher penetration ability 
of the Hx group into the blood vessel as compared with the Dec group. 
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Figure 3.4. Bonding strength of t-hm-AlGltn films on the porcine blood vessel. (A) Effect of chain length and 
density of hm-AlGltns on the bonding strength. Data are shown as the average ± S.D. of three samples (* p < 0.05, 
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** p ≥ 0.05); (B) Cross-sectional views of the film-tissue interface after bonding strength measurement of (a) 
t-AlGltn; (b) t-42HxAlGltn; (c) t-38DecAlGltn; and (d) t-44SteAlGltn. Scale bar: 50μm. Red arrows show the 
sites t-hm-AlGltn remained. 
Recently, we reported that a tissue adhesive composed of cholesteryl group-modified Gltn and 
disuccinimidyl tartrate showed excellent bonding ability onto porcine arterial media14–16. From histological 
observations, a thick adhesive layer was found on the media surface even after the bonding strength measurement. 
In the present case, only a thin adhesive layer was observed. The t-hm-AlGltn films seemed to be much stiffer 
than the cholesteryl group-modified Gltn-based adhesive; therefore, film remaining on the blood vessel surface 
could be hard even when the films were bonded strongly. 
 
 
3.4.7. Cell Adhesion onto Thermally Crosslinked hm-AlGltn Films 
 
 To compare cell adhesivity onto the films, L929 cells were seeded onto t-AlGltn, t-42HxAlGltn, 
t-38DecAlGltn, and t-44SteAlGltn films. After being cultured for 5 min, the number of adhered cells was counted. 
Also, the morphology of the adhered cells was observed using a scanning electron microscope (SEM). 
Figure 3.5 shows SEM images of L929 cells adhered onto t-hm-AlGltn films or culture plate dishes 
after being cultured for 5 min. The cells on the tissue culture plate show a spherical shape (Figure 3.5e). However, 
the cells on each t-(hm-)AlGltn surface, especially on t-42HxAlGltn surface, spread more extensively on the 
t-42HxAlGltn surface (Figure 3.5a–d), indicating that short side chains such as Hx could easily interact with the 
cell membrane. 
Many more L929 cells adhered on t-42HxAlGltn than on t-AlGltn, t-38DecAlGltn, and t-44SteAlGltn 
(data is not shown). The obvious difference may come from the easy Hx interpenetration into the cell membrane 
due to its low melting point. 
 
(a) (b) (c) (d) (e)
 
Figure 3.5. L929 adhesion onto t-hm-AlGltn films after being cultured for 5min. Morphology of L929 cells on 
t-hm-AlGltn films ((a) t-AlGltn; (b) t-42HxAlGltn; (c) t-38DecAlGltn; (d) t-44SteAlGltn and (e) tissue culture 
plate). Scale bar: 5 μm. 
 
The results indicate that the introduced hydrophobic group Hx interacts with the tissue components, 
including collagen and the cell membrane. This means that the Hx group penetrated into the hydrophobic domains 
of the tissue, such as the hydrophobic amino acid residue and the phospholipids of the cell membrane. Figure 3.6 
shows the effect of the chain length and the density on the ability of t-hm-AlGltn molecules to bond onto a blood 
vessel. When long chains such as those of the Ste and Dec groups are introduced into the AlGltn molecules, the 
resulting hm-AlGltn cannot easily interact with collagen molecules on the surface of the blood vessel because of 
their higher melting points and volume exclusion. Also, longer chains with lower mobility can hardly interact with 
hydrophobic groups because of hydrophobic amino acids in blood vessels. On the other hand, t-42HxAlGltn 
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molecules with dense and short chains with a lower melting point easily interact with blood vessels and form 
stronger bonds. 
In this study, t-24DecAlGltn and t-38DecAlGltn were employed for comparison. If DecAlGltns with a 
slightly higher introduction ratio like t-30DecAlGltn and t-40DecAlGltn were compared, the bonding strength 
would be weaker than t-24DecAlGltn and t-38DecAlGltn. The hypothesis is from our previous data that hm-Gltns 
with a much higher introduction ratio, over 50% introduction ratios, bonded more weakly than t-hm-Gltns with 
appropriate introduction ratios. The higher amount of alkyl chains can agglomerate by hydrophobic interaction in 
the film, therefore, there will be less hydrophobic group which can interact with the hydrophobic group in the 
ECM of the blood vessel. 
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Figure 3.6. Schematic illustration of the bonding behavior of t-hm-AlGltns with various hydrophobic chain 
lengths and densities. 
 
 
3.5. Conclusion 
 
 Thermally crosslinked film adhesives composed of hydrophobically modified AlGltn with Hx (C6), Dec 
(C10), or Ste (C18) were fabricated and their bonding behaviors on porcine blood vessels were evaluated. The 
t-42HxAlGltn film with short and dense hydrophobic groups showed higher wettability, lower water content, and 
stronger bonding to the blood vessel compared to the other t-hm-AlGltn films. 
The t-42HxAlGltn and t-38DecAlGltn films remaining after bonding strength measurement were 
confirmed by histological observation. L929 cells rapidly adhered and extended onto the t-42HxAlGltn film 
compared with other films. These results indicate that the t-42HxAlGltn film has potential for biomedical 
applications as a film adhesive. 
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Chapter 4 
 
Enhanced Angiogenesis of Growth Factor-Free 
Porous Biodegradable Adhesive Made with 
Hexanoyl Group-Modified Gelatin  
  
 
4.1. Summary 
 
 The bonding behavior of hexanoyl (Hx: C6) group-modified alkaline-treated gelatin (HxAlGltn) porous 
films ((P)HxAlGltn) on the porcine intestine was evaluated. (P)HxAlGltns with various porosities were prepared 
by the salt-leaching method for various solid-liquid ratios. (P)HxAlGltns bonded more strongly to porcinal 
intestine surfaces than did porous AlGltn films ((P)AlGltns). L929 cells cultured on (P)HxAlGltns showed  
adhesivity than cells cultured on (P)AlGltns. Faster tissue infiltration and a shorter degradation time of highly 
porous (P)HxAlGltns were observed after implantation in rat subcutaneous tissues. The angiogenic markers CD34 
and -SMA were highly expressed around (P)HxAlGltns that had high porosity. These results indicated that 
highly porous (P)HxAlGltns have advantages with respect to not only bonding strength on wet soft tissues, but 
also angiogenesis. 
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4.2. Introduction 
 
 Fast and effective wound care requires the promotion of processes involved in the acute inflammatory 
and growth phases, including angiogenesis and tissue migration. Biomaterials for wound care should demonstrate 
strong tissue adhesion under wet conditions to close the wound and tissue regeneration properties, including cell 
adhesion, angiogenic activity, and appropriate porosity. 
Biomaterials that are developed for strong adhesion to soft tissues under wet conditions are classified 
into three types: nanomaterials, biomimetic materials, and naturally derived polymer-based materials. 
Nanomaterials include nanoparticles1 and nanosheets2 and are driven mainly by van der Waals’ forces. 
Biomimetic materials are typically prepared by introducing a catechol moiety3,4, which is the major component of 
the marine mussel adhesion protein, into biocompatible polymers under wet conditions. Gecko feet5 have been 
reported to adhere to tissue/organ surfaces with fibrous structures exhibiting strong bonding ability on solid 
substrates. Naturally derived polymers including gelatin6, alginate7, and albumin8-11 have been employed as basic 
components of tissue adhesive materials.  
Highly porous materials12 have been proposed for faster tissue regeneration and for their ability to 
release angiogenic factors13-22; however, angiogenic factors such as basic fibroblast growth factor (bFGF)23-27 and 
vascular endothelial growth factor (VEGF)28-30 are expensive cytokines and are not stable in physiological 
environments31-34.  
Hexanoyl (Hx: C6) group-modified heparin has a high binding constant with bFGF35, indicating that 
Hx-modified heparin can be a reservoir for bFGF. Furthermore, we recently reported that a liquid tissue adhesive 
containing hydrophobically modified gelatin (hm-Gltn) shows higher interfacial bonding strength to soft tissues 
under wet conditions than an adhesive containing non-modified, original Gltn36-38. Moreover, film-type adhesives 
composed of hm-Gltn, especially Hx-Gltn, bond strongly to soft tissue under wet conditions39,40. These results 
suggest that biopolymers combined with the Hx group will show high affinity with angiogenic factors such as 
bFGF and VEGF.  
Hx group-modified alkali-treated Gltn (HxAlGltn) films with porous structures were fabricated using 
NaCl as a porogen to evaluate soft tissue bonding under wet conditions. Furthermore, the angiogenic properties 
and mechanisms of the resulting films were clarified. 
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4.3. Materials and Methods 
 
 
4.3.1. Materials 
 
  Alkaline-treated gelatin (AlGltn) named BeMatrix® derived from porcine skin was kindly donated by 
Nitta Gelatin Inc. (Osaka, Japan). Ethanol (EtOH), dimethyl sulfoxide (DMSO), triethylamine (TEA), 
2,4,6-trinitrobenzenesulfonic acid (TNBS), hydrochloric acid (HCl), sodium dodecyl sulfide (SDS), 10% formalin 
neutral buffer solution, tert-butyl alcohol, sodium chloride (NaCl), L-lactic acid (LA) and vascular endothelial 
growth factor (VEGF) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Hexanoyl (Hx: 
C6) chloride was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Porcine intestine and anti CD34 Rat 
(Goat) antibody was purchased from Funakoshi Corporation (Tokushima, Japan). L929 cells were purchased from 
RIKEN BRC CELL BANK, RBRC-RCB2619 (Ibaraki, Japan). Fetal bovine serum (FBS), phosphate buffered 
saline (PBS) and RPMI-1640 (SIGMA, R8758) were purchased from Lonza (Basel, Switzerland). WST-8 was 
purchased from Dojindo Laboratories (Kumamoto, Japan). Fibronectin (FN) and bFGF were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Citrate acid derived crosslinker (TSC) was synthesized as previously 
reported18. All chemicals were used without further purification. 
 
 
4.3.2. Synthesis and Characterization of HxAlGltn 
 
 Following previously reported methods39,40, Hx group-introduced hm-AlGltn (HxAlGltn) was prepared 
by the reaction between Hx chloride and primary amino groups of AlGltn. First, AlGltn (10 g) was fully dissolved 
into 99 mL of DMSOat 80 °C. Then, 1 mL of hexanoyl (Hx: C6) chloride was added to the AlGltn/DMSO solution 
to obtain 100 mL of 10 w/v% AlGltn/DMSO solution under a dry N2 atmosphere at room temperature. One 
milliliter of TEA was subsequently added to the AlGltn solution and stirred for 17 h at room temperature. The 
resulting HxAlGltn/DMSO solution was poured into 300 mL of cold EtOH and stirred for 1 h. Subsequently, the 
HxAlGltn precipitate was washed twice with 300 mL of cold EtOH followed by evaporation under a vacuum to 
leave a white cake, and the yields were calculated. 
The modification ratio for Hx groups in HxAlGltn was quantified using a previously reported method 
with TNBS36,37,55-57. Briefly, HxAlGltns or the original AlGltn was dissolved into DMSO to obtain 0.05 w/v% 
solutions. Then, 100 L of 0.1 v/v% TEA/DMSO, 50 L of 0.1 w/v% SDS/DMSO, and 100 L of 0.1 w/v% 
TNBS/DMSO were added to 100 L of the HxAlGltn or AlGltn/DMSO solution followed by incubation at 37 °C 
for 2 h under light-shielding conditions. Then, 50 L of 2N HCl/DMSO was added to stop the reaction. Finally, 
the intensity of light absorbance was measured spectrophotometrically at 340 nm using a microplate reader 
(GENios A-5082, Tecan Japan, Kanagawa, Japan). The percentage of amino groups substituted with Hx chloride 
was then calculated based on the relative intensities of HxAlGltn compared with the original AlGltn. 
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4.3.3. Preparation and Characterization of (P)HxAlGltns and (P)AlGltns 
 
 HxAlGltn was dissolved in 10% LA-DMSO solvent to prepare 25 w/v% HxAlGltn solutions, and TSC 
(a citrate acid-derived crosslinker synthesized as previously reported58) was added to 10 mL of the 
HxAlGltn/LA-DMSO solution to match the amount of NHS group in TSC and the amount of amino group 
residues of the HxAlGltn molecule, and the TSC-HxAlGltn/DMSO was stirred quickly. The required amount of 
NaCl (for liquid-solid ratios of 1/1, 2/1, 3/1, 4/1, or 5/1 (w/w)) was added to the solution and mixed to disperse the 
NaCl uniformly. The solutions were packed into zipper bags (Unipack, Seisannipponsha Ltd., Tokyo, Japan) and 
the compounds were put between glass plates with 1-mm thick silicone spacers. After overnight crosslinking, the 
obtained NaCl-HxAlGltn gels were immersed in 4 °C ultra-pure water for 3 days with frequent water changes to 
remove LA-DMSO, NaCl, NHS, and unreacted TSC. The hydrogels were frozen at -80 °C and were lyophilized 
for 3 days to obtain the (P)HxAlGltn film. The (P)AlGltns were fabricated following the same method. 
 The porosity of each porous film was determined by a water content calculation considering the weight 
of water absorbed for porous films with cold water filled-pores (Wf) and the weight of water absorbed for porous 
films with empty pores (We). The porosity was calculated using the following formula: 
Porosity (%) = (Wf – We)/Wf × 100. 
 
4.3.4. Measurement of the Mechanical Strength of (P)HxAlGltns and (P)AlGltns 
 
 Each film was cut out into 5 mm × 10 mm rectangle shape, and both ends in 2.5 mm × 5 mm were 
bonded on the end of 10 mm × 20 mm plastic sheets by GelBoy (LOCTITE, Japan Henkel, Japan). Then, both 
ends of the plastics of the samples were attached to probes and tensile tests were performed by 10 mm/minute 
speed. For tensile test of swollen films, the samples were swollen in 37 ºC ultra-pure water for 5 min (n = 3). 
 
 
4.3.5. Measurement of the Bonding Strength Between the Intestine and (P)HxAlGltns or 
(P)AlGltns and Observations of the Peeling Interface of Porous Film-Intestines 
 
 Porcinal intestine was dissected into disks 4 mm in diameter with a dermal punch. The dissected 
intestine was bound to the top of the probe with a cyanoacrylate adhesive, GelBoy. The porous films were also 
punched out into circles 7 mm in diameter and fixed on a 37 °C heated plate with scotch tape (3M, Tokyo, Japan) 
with a hole that was 4 mm in diameter. The bond strength was then measured using a Texture Analyzer (TA-XT2i, 
Stable Microsystems, Surrey, UK) (n = 3) under the following conditions: 180 sec contact time, 40 g/mm2 applied 
force, and 10 mm/min tracking speed. 
After the measurement, samples were fixed in a 10% formalin neutral buffer solution and stained with 
hematoxylin and eosin (H&E). The cross sections of the peeling interfaces were observed under an optical 
microscope (BX51, Olympus, Japan). 
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4.3.6. Cell Cultures on (P)HxAlGltns and (P)AlGltns 
 
 A murine fibroblast cell line, L929, was used to evaluate cell adhesion and viability on (P)HxAlGltns 
and (P)AlGltns. L929s were first cultured in a medium (RPMI-1640, SIGMA, R8758) containing 2 v/v% fetal 
bovine serum. Each (P)AlGltn or (P)HxAlGltn disc, 1 cm in diameter, was placed on 24-well plates and a glass 
ring was put on each film. All samples were swollen with RPMI without FBS. Then, L929 cells (5.0 × 104 cells) 
were cultured for 1, 4, 8, or 24 h. After incubation with 10 L/well of WST-8 for 1 h, light absorbance was 
measured at 450 nm (n = 3). The films were rinsed with 2 mL of PBS twice, and the cells were fixed with 10% 
formalin neutral buffer solution. 
After drying, the L929 cell morphologies were observed with a scanning electron microscope (SEM, 
JSM-5600, JEOL, Tokyo, Japan). In brief, the cells and the porous films were gradually dehydrated with a 50 to 
99 v/v% ethanol/water solution followed by one wash with 50 v/v% tert-butyl alcohol/EtOH and two 100% 
tert-butyl alcohol immersions and freeze-drying at -80 °C. Then, the cells were sputtered with Pt and observed by 
SEM. 
 
 
4.3.7. Subcutaneous Implantation of (P)HxAlGltns and (P)AlGltns 
 
 Each porous film was cut into a disk, 1 cm in diameter, and sterilized with ethylene-oxide gas. The disks 
were implanted subcutaneously in rats (Wistar, 7-week-old males) for 3, 7, 14, and 28 days. After the term, each 
tissue including the porous film disk was removed, fixed in 10% formalin neutral buffer solution, and subjected to 
H&E staining.  
 
 
4.3.8. Angiogenesis Evaluation around the Porous Films with CD34 and -SMA Immunostaining 
 
 The 10% formalin neutral buffer solution-fixed samples at 7, 14, and 28 days after implantation were 
immunostained with anti-CD34 rat (goat) antibody and for -SMA. The number and area of CD34 or -SMA 
regions per unit area and the densely marked area per unit area were calculated using ImageJ (n = 3). 
 
 
4.3.9. Determination of dissociation constants between HxAlGltn/AlGltn and FN/bFGF/VEGF 
 
 Either HxAlGltn or AlGltn was fixed onto the carboxymethyl-fixed sensor chip (CM5) (GE Healthcare 
Japan Corp., Tokyo, Japan) by the amine coupling method. The carboxyl group was activated by NHS to fix the 
Gltn molecules via its amino group, and ethanolamine was then used for NHS residue blocking. The fixation 
process was performed with an amine coupling kit (BR-1000-50, GE Healthcare Japan Corp.) including EDC 
(N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride), NHS, and 1 M ethanolamine hydrochloride 
solution (pH 8.5). A flow of 1000 g/mL of HxAlGltn/10 mM acetic acid buffer (pH 4.0) for 7 min at 5 L/min 
speed was used for amine coupling. The procedure was also implemented with 5, 50, and 100 g/mL of FN/PBS 
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solution, 10, 25, and 50 g/mL of bFGF/PBS solution, or 5, 7.5, and 10 g/mL of VEGF/PBS for 3 min at a flow 
rate of 20 L/min. After the interaction, the association and dissociation constants were calculated using a 
program (n = 3). 
 
 
4.3.10. Statistical Analysis 
 
 Statistical analysis was carried out using Welch’s t-tests. Statistically significant differences were 
accepted when p < 0.05. The data are shown as means ± standard deviation (SD). 
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4.4. Results and Discussion 
 
4.4.1. Synthesis and Characterization of HxAlGltn 
 
 Following our previous method, HxAlGltn was synthesized by a reaction between the amino groups of 
AlGltn molecules and Hx chloride (Figure 4.1A)39,40.. The degree of substitution of amino groups with Hx groups 
was 27%, as determined using the 2,4,6-trinitrobenzosulfonic acid (TNBS) method40. 
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Figure 4.1. Preparation of the porous films. (A) HxAlGltn synthesis after the reaction between AlGltn and Hx 
chloride. (B) Macro/microscopic images of tissue-adhesive porous bodies fabricated without/with NaCl using 
AlGltn/HxAlGltn. Scale bars: 5 mm in macroscopic and 100 m in microscopic. (c) Porosity of (P)AlGltns or 
(P)HxAlGltns with various amounts of NaCl (●(P)AlGltns and ○(P)HxAlGltns). Data represent the means ± 
SD of three samples (n = 3). 
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4.4.2. Preparation of porous films 
 
 The porous AlGltn or HxAlGltn films ((P)AlGltns and (P)HxAlGltns, respectively) were fabricated 
using the salt-leaching method with NaCl particles as a porogen. To crosslink AlGltn or HxAlGltn, trisuccinimidyl 
citrate (TSC) was employed41 (Figure 4.1B). Solid-liquid ratios (SLR) of NaCl and AlGltn or HxAlGltn/(10% 
lactic acid (LA)-dimethyl sulfoxide (DMSO)) ranged from 0/1 to 5/1, and the porosity of each porous film was 
regulated with an accuracy of 1% to 65% (Figure 4.1C).  
 
 
4.4.3. Mechanical Strength of the (P)HxAlGltns and the (P)AlGltns  
 
The tensile strength of the porous films declined in accordance with the porosity-increase. 
Under both wet and dry condition, (P)HxAlGltns were lower in mechanical strength compared with 
(P)AlGltn (Figure 4.2). In dried state, the strength declining was outstanding between SLR0/1 to 1/1, 
however, those over SLR1/0 were not outstanding (Figure 4.2A). In wet state, there was rather 
gradual mechanical strengths declining from SLR0/1 to 1/1 and over 1/1 (Figure 4.2B). Under both 
wet and dry state, (P)HxAlGltns were weaker compared with (P)AlGltns with each SLR.  
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Figure 4.2. Bulk strength of the porous films. Tensile strength of (P)AlGltns (●) and (P)HxAlGltns (○) under 
dry (a) or wet (b) state. n=3. 
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Each Gltn molecule can interact with other Gltn molecules, however, Hx group inhibited 
HxAlGltn interaction with other HxAlGltn moiety by volume exclusion. The inhibition resulted in 
weaker bulk strength in both wet- and dry- (P)HxAlGltns than (P)AlGltns. The SLR dependent 
declining of the bulk strength was derived from inner wall thickness, and over SLR3/1, there were 
little space for packing NaCl particles in the solution and slight amount of holes without any NaCl 
particles and liquid were inserted resulted in gradual increasing through hole, or declining of the 
beam thickness. Under the wet state, all the pores were full with water and the HxAlGltn and 
AlGltn molecules can move more freely compared with those under dried state, therefore, the 
interaction between each molecule got weaker resulted in rather weak bulk strengths. 
 
 
4.4.4. Bonding Strength of the (P)HxAlGltns and (P)AlGltns on the Intestine Surface 
 
Before measuring bonding strength, the loading weight/moment was optimized using (P)AlGltn-SLR4/1. 
Pressure applied at 40 g/mm2 for 3 min was found to be the optimum condition (Figure 4.3). Therefore, these 
conditions were applied to all further experiments. The same conditions were optimal for the 
(P)HxAlGltn-SLR4/1-intestine bonding measurements (Figure 4.4.). 
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Figure 4.3. Optimization of loading weight and time for bonding strength measurements. The dependence on 
loading time and loading pressure on measurements of bonding strength between (P)AlGltns and the porcinal 
intestine. (A) Loading time effect on bonding strength for 20 g/mm2 at 37 °C (B) Loading pressure effect on bond 
strength for 3 min-loading at 37 °C. Data are the means ± SD of three samples (n = 3), *p < 0.05, **p > 0.05. 
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Figure 4.4. Determination of loading conditions for (P)HxAlGltn-intestine bonding strength measurements. 
Dependence on loading time of the bond strength between the (P)HxAlGltn film fabricated with 4/1-SLR and the 
porcinal intestine. Time-dependent bonding strength for 40 g/mm2 at 37 °C. Data are the means ± SD of three 
samples (n = 3), *p < 0.05, **p > 0.05. 
 
The bonding strength between porous films and the porcinal intestine indicated an advantage of 
(P)HxAlGltns relative to (P)AlGltns; for each SLR except SLR0/1, it had 2 to 3 times greater bonding strength 
(Table 4.1). In particular, (P)HxAlGltn bonded the strongest (98.7 ± 6.4 kPa) to the intestine surface in porous 
films when the porosity was 62%. In contrast, the bonding strength of (P)AlGltn to the intestine surface was 
below 40 kPa for all porosities.  
 
Table 4.1. Bonding strength between porous membrane and intestine 
(P)AlGltn: porous alkaline-treated gelatin film.
(P)HxAlGltn: porous hexanoyl group modified AlGltn film.
All the measurement was under n=3 condition.
The asterisks mean p < 0.05 compared with 45% porous
AlGltn under Aspin-Welch’s t-tests.
Abbreviation Solid-Liquid
Ratio
Porosity Bonding 
Strength
(w/w) (%) (kPa)
(P)AlGltn-SLR0/1 0/1 0 25.2 ± 1.0
(P)AlGltn-SLR1/1 1/1 31 38.9 ± 2.4
(P)AlGltn-SLR2/1 2/1 45 40.1 ± 6.7
(P)AlGltn-SLR3/1 3/1 49 39.0 ± 9.3
(P)AlGltn-SLR4/1 4/1 52 31.2 ± 1.3
(P)AlGltn-SLR5/1 5/1 64 26.6 ± 15.6
(P)HxAlGltn-SLR0/1 0/1 1 25.6 ± 1.0*
(P) HxAlGltn-SLR1/1 1/1 17 77.8 ± 12.3* 
(P) HxAlGltn-SLR2/1 2/1 39 94.9 ± 9.4*
(P) HxAlGltn-SLR3/1 3/1 50 73.2 ± 16.1*
(P) HxAlGltn-SLR4/1 4/1 62 98.7 ± 6.4*
(P) HxAlGltn-SLR5/1 5/1 65 77.0 ± 4.1*
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Figure 4.5 shows that the intestine tissue remained on the porous films after the bonding 
strength was measured. Thin tissue was found on the (P)AlGltn-SLR4/1 surface (Figure 4.5A); 
however, thick tissue remained on (P)HxAlGltn-SLR4/1 (Figure 4.5B) , indicating that the strong 
bonding of highly porous (P)HxAlGltn caused tissue destruction. These results showed that tissue 
destruction was highly correlated with bonding strength corresponded with the bonding strength.   
 
(A)
(B)
F
F
T
T
 
Figure 4.5. Bonding behavior between porous films and porcinal intestine surfaces. Hematoxylin and 
eosin-stained intestine remnants remained on the (P)AlGltn-SLR4/1 (A) or (P)HxAlGltn-SLR4/1 (B) interfaces 
after peeling strength measurements were taken. F: Film, T: tissue, arrows: the limb of attached tissue. Scale bars: 
20 m. 
 
(P)HxAlGltns-SLR1/1 to SLR5/1 bonded approximately 3 times more strongly than (P)AlGltns for each 
SLR. This result indicates that the porous structure effected wet tissue bonding when the Hx group was included. 
Hematoxylin and eosin staining after bonding strength was measured indicated that film remnants (dark purple) 
remained on the tissue surfaces (pink purple) and vice versa (Figure 4.6). Tissue remnants could be observed on 
the (P)HxAlGltns surfaces (Figure 4.6i-l); however, little (P)HxAlGltn remained on the tissue surface (Figure 
4.6m-p). In the case of (P)AlGltns, there was no remnant on the tissue surfaces (Figure 4.6e-h) and no tissue 
remained on (P)AlGltns (Figure 4.6a-d). These results suggest that strong binding of (P)HxAlGltns results in 
adherence failure. Compared with flat-structured surfaces, porous surfaces facilitate moisture absorption from wet 
tissue surfaces. The Hx group penetrated the cell membrane of the tissue surface and easily interacted with the 
hydrophobic region of the extracellular matrix including hydrophobic amino acids owing to its low melting point 
and resulting high mobility. Without the Hx group, (P)AlGltns could not strongly bind to the tissue surface, 
irrespective of SLR. 
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Figure 4.6. Peeling interface after bonding strength measurements. Hematoxylin and eosin-stained cross sections 
of the interfaces between porcinal intestines and porous films after bonding strength was measured. (a–d) 
(P)AlGltn surfaces, (e–h) (P)AlGltn-peeled intestine surfaces, (i–l) (P)HxAlGltn surfaces and (m–p) 
(P)HxAlGltn-peeled intestine surfaces. The solid-liquid ratio of each film was 0/1 (a, i), 1/1 (b, j), 4/1 (c, k), or 5/1 
(w/w) (d, l). 
 
 
4.4.5. Cellular Proliferation and the Morphology on the (P)HxAlGltns and (P)AlGltns 
 
For fast tissue regeneration, cell adhesion to the material is also an important property. The initial cell 
adhesion and subsequent viability on the porous films were investigated by culturing L929 on (P)AlGltns and 
(P)HxAlGltns without FBS. The number of cells on (P)AlGltn-SLR1/1 was constant after culturing for 24h; on 
(P)AlGltn-SLR4/1, it increased until 8 h and decreased by 24h of culture. In contrast, a large number of L929 cells 
were found on the (P)HxAlGltns after 24h, especially on (P)HxAlGltn-SLR4/1 (Figure 4.7A). Throughout the 
cultivation period, the cultured L929 cells extended more widely on the (P)HxAlGltns than on the (P)AlGltns 
(Figure 4.7B). The expansion of cells on the (P)HxAlGltns depended on the culturing time. The cells on 
(P)AlGltns showed minimal differences among culturing times. Cells on (P)HxAlGltn-SLR4/1 were flatter than 
those on (P)HxAlGltn-SLR1/1. 
The duplication time of L929 is 14h, and the culture period was sufficient for comparisons. The 
transition in cell number and cell morphology indicated that the cells proliferated easily on highly porous 
(P)HxAlGltns. It is well known that the stiffness of the scaffold effects the reaction of cells, including 
proliferation44,45. A shorter carbon chain acts as surfactant, inducing inflammation. As shown in Figure 4.7B, the 
softness of (P)HxAlGltn-SLR4/1 in wet conditions and the shorter carbon chain of the Hx group effected cellular 
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activation via a signaling pathway resulting in high proliferation. In addition, the Hx group facilitated reactions or 
insertions to the cellular membrane, resulting in elongation of the pseudopodia. 
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Figure 4.7. L929 cell proliferation and cell morphology. (A) L929 cell viability for 1-, 4-, 8-, and 24-h cultures on 
the porous films fabricated with various solid-liquid ratios. White column: (P)AlGltn-SLR0/1, light gray column: 
(P)AlGln-SLR4/1, dark gray column: (P)HxAlGltn-SLR0/1, black column: (P)HxAlGltn-SLR4/1. n = 3, * p < 
0.05. (B) L929 cell morphology after 1 h (a~d), 4 h (e~h), 8 h (i~l), or 24 h (m~p) of culturing on 
(P)AlGltn-SLR0/1 (a, e, i, m), (P)AlGltn-SLR4/1 (b, f, j, n), (P)HxAlGltn-SLR0/1 (c, g, k, o), or 
(P)HxAlGltn-SLR4/1 (d, h, l, p) surfaces. Scale bar is 5 m. 
 
 
4.4.6. Tissue reaction for (P)HxAlGltns and (P)AlGltns 
 
 The disc-shaped porous films with diameters of 1 cm were subcutaneously implanted in the back of rats 
for 3, 7, 14, and 28 days to evaluate biodegradation, tissue infiltration, and angiogenesis. For all porosities, 
(P)HxAlGltns degraded faster than (P)AlGltns. Specifically, (P)HxAlGltn with a porosity of 62% degraded within 
28 days, and its degradation was faster than that of (P)HxAlGltns with different porosities (Figure 4.8A).  
Tissue infiltration into (P)HxAlGltns was also detected at an earlier stage, and the surrounding tissue 
was completely infiltrated 7 days after implantation (Figure 4.8B). Moreover, more red blood cells were found 
around (P)HxAlGltns than (P)AlGltns. 
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Figure 4.8. Behavior of the porous films under rat subcutaneous. (A) Biodegradation of (P)AlGltns and 
(P)HxAlGltns fabricated with various solid-liquid ratios under rat subcutaneous after 3 to 28 days implantation. 
(B) H&E stained tissue and (P)AlGltns or (P)HxAlGltns fabricated with various solid-liquid ratios implanted 
under rat subcutaneous for 7 to 28days. 
 
The faster degradation of (P)HxAlGltn-SLR4/1 could be related to its lower bulk strength and cell 
proliferation/infiltration ability. Matrix metalloproteinases (MMPs), splitting enzymes that degrade the 
extracellular matrix, is widely expressed in fibroblasts46-48. Therefore, fibroblast proliferation and the accessibility 
of AlGltn molecules accelerated (P)HxAlGltn-SLR4/1 degradation via MMPs. Moreover, the highly porous 
structure and Hx group-derived cellular activation resulted in faster tissue infiltration. 
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4.4.7. Angiogenesis Evaluation around the Porous Films Based on CD34 and -SMA 
Immunostaining 
 
 valuate angiogenesis after the implantation of porous films, CD34 and -smooth muscle actin (-SMA) 
immunostaining was performed. A larger positive area indicating CD34, which is a marker of immature 
endothelial cells or early vascularization, was found around (P)HxAlGltn than around (P)AlGltn (Figure 4.9A) 
with SLR 0/1 and 4/1. Quantitative data analyzed using ImageJ indicated more CD34 expression around 
(P)HxAlGltn in the early stage (i.e., the first 7 days), especially for a porosity of 62% (Figure 4.9Ba). However, 
the area of the vascular holes was constant from 7 to 28 days (Figure 4.9Bb) for almost all the implanted materials. 
The number of vascular areas marked by CD34 staining did not clearly differ between the porous films (Figure 
4.9Bc). 
The marker of mature endothelial cells or late vascularization, -SMA, was also observed around both 
(P)AlGltn and (P)HxAlGltn (Figure 4.10A and Ba). Furthermore, the -SMA-positive area decreased over time 
when (P)AlGltn-SLR4/1 and (P)HxAlGltn-SLR4/1 were implanted. (P)HxAlGltn had a large vascular hole area 
that was surrounded by -SMA (Figure 4.10Bb). Many vascular regions formed around (P)HxAlGltn until 14 
days after implantation (Figure 4.10Bc). (P)AlGltn showed a disadvantage with respect to number of vascular 
holes, vascular hole area, and -SMA-positive area. 
High expression of CD34 at an early stage and a wide vascular hole area with CD34 staining were 
observed over a 14-day period. These phenomena indicated that (P)HxAlGltn-SLR4/1 had the advantage of faster 
induction of infant vascular endothelial cells and faster formation of immature large vascular walls around the 
film. CD34 is a marker of immature cells; therefore, the sharp decline in the CD34-positive area after implantation 
from 7 to 14 days is consistent with the longer implantation period. The -SMA-positive area of (P)HxAlGltn was 
larger than the CD34-positive area 14 days after implantation, indicating the promotion of mature endothelium 
formation. The proportional changes in the number of -SMA-marked vascular regions and the -SMA-marked 
vascular area indicate mature microvascular formation with congenial thickness around the porous films, 
especially around the (P)HxAlGltn-SLR4/1. There were large -SMA-positive areas around (P)AlGltn-SLR4/1; 
however, few vascular holes formed around (P)AlGltn-SLR4/1, indicating that the angiogenic properties of 
(P)AlGltn-SLR4/1 were slower compared with those of (P)HxAlGltn-SLR4/1. 
VEGF is secreted from various cells including fibroblasts to facilitate angiogenesis49-51. In the cell 
culture experiment, fibroblasts showed high cytocompatibility with (P)HxAlGltn-SLR4/1, and fibroblast-like cells 
around the (P)HxAlGltn-SLR4/1 produced VEGF and MMP to induce immature vascular endothelial cells and 
promoted microvascular maturation. 
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Figure 4.9. Angiogenesis analysis with CD34 staining. (A) Microscopic images of CD34-stained tissues and 
(P)AlGltns or (P)HxAlGltns fabricated with various solid-liquid ratios after subcutaneous implantation in rats for 
7, 14, and 28 days. (B) Evaluation of angiogenesis based on the (a) CD34-positive area, (b) CD34-encircled 
vascular area, and (c) CD34-encircled vascular number. White column: 7 days, gray column: 14 days, black 
column: 28 days. D: completely degraded. Data are the means ± SD of three samples (n = 3), * p < 0.05. Scale 
bar: 100 m. 
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Figure 4.10. Angiogenesis analysis with -SMA staining. (A) Microscopic images of -smooth muscle actin 
(-SMA)-stained tissues and (P)AlGltns or (P)HxAlGltns fabricated with various solid-liquid ratios after 
subcutaneous implantation in rats for 7, 14, and 28 days. (B) Evaluation of angiogenesis based on the (a) 
-SMA-positive area, (b) -SMA-encircled vascular area, and (c) -SMA-encircled vascular number. White 
column: 7 days, gray column: 14 days, black column: 28 days. D: completely degraded. Data are the means ± SD 
of three samples (n = 3), * p < 0.05. Scale bar: 100 m. 
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4.4.8. Fibronectin (FN), Basic Fibroblast Growth Factor (bFGF), and Vascular Endothelium 
Growth Factor (VEGF) Affinity with HxAlGltn 
 
 Fibronectin (FN) is a well-known cell adhesion protein owing to its arginine-glycine-asparagine (RGD) 
binding site residues. Furthermore, both basic fibroblast growth factor (bFGF) and vascular endothelium growth 
factor (VEGF) stimulate angiogenesis in vivo25,28,42,43. To clarify the angiogenesis mechanisms of (P)HxAlGltns, 
the affinity of these biofunctional proteins with (P)HxAlGltns was determined using surface plasmon resonance. 
Table 4.2 shows the dissociation constants (KD) for FN, bFGF, and VEGF from AlGltn or HxAlGltn molecules. 
The bFGF dissociation constant was smaller for AlGltn than HxAlGltn (HxAlGltn: 1.02 × 10-6, AlGltn: 4.77 × 
10-9), indicating that AlGltn shows higher affinity for bFGF than does HxAlGltn. Both FN and VEGF 
demonstrated stronger binding to HxAlGltn molecules than to AlGltn molecules. In particular, the VEGF 
dissociation constant was 17.2 times smaller for AlGltn than HxAlGltn (HxAlGltn: 2.90 × 10-8, AlGltn: 5.00 × 
10-7). Therefore, VEGF was more involved in angiogenesis after the implantation of (P)HxAlGltn.  
 
Table 4.2. Dissociation constants of proteins from AlGltn/HxAlGltn 
Dissociation: KD (M)
Fibronectin bFGF VEGF
AlGltn 6.38 x 10-6 4.77 x 10-9 5.00 x 10-7
HxAlGltn 1.60 x 10-6 1.02 x 10-6 2.90 x 10-8  
 
The bFGF released from heparin is related to Hx-group modification27. Therefore, it can be 
hypothesized that angiogenesis factors including bFGF interact with HxAlGltn modified with the Hx group to 
facilitate angiogenesis. Unexpectedly, VEGF showed higher affinity to HxAlGltn than did bFGF. Therefore, 
angiogenesis around (P)HxAlGltn-SLR4/1 could largely depend on the capture and release of VEGF from 
HxAlGltn molecules. The mechanism of angiogenesis induced by HxAlGltn is follows. After implantation of 
(P)HxAlGltn, various types of inflammatory cells including macrophages infiltrate the (P)HxAlGltn. Then, 
cytokines and angiogenic factors including VEGF are released from inflammatory cells. As shown in Figure 
4.11A, Hx group on the  (P)HxAlGltn stimulates angiogenesis more than (P)AlGltn. And the Figure 4.11 shows, 
(P)HxAlGltns induce inflamation than (P)AlGltns. The released VEGF binds to (P)HxAlGltn. This VEGF binding 
behavior is expected based on the surface plasmon resonance analysis, as shown in Table 4.2. Inflammatory cells 
also release MMP52-54; therefore, VEGF bound to (P)HxAlGltn is released from the (P)HxAlGltn after the 
digestion of HxAlGltn. As a result, released VEGF bound to (P)HxAlGltn stimulates angiogenesis (Figure 4.11B). 
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Figure 4.11. Bonding and angiogenesis mechanisms of (P)HxAlGltn. (A) The bonding mechanism of 
(P)HxAlGltn to soft tissue. The Hx group of HxAlGltn anchored to the lipid bilayer of the epithelium on the 
intestine surface. (B) Angiogenesis induction via (P)HxAlGltn. Secreted VEGF was bound to the HxAlGltn 
molecule subcutaneously, followed by HxAlGltn degradation via proteolysis with protease, and the 
VEGF-HxAlGltn moiety and endothelium interaction resulted in angiogenesis. 
 
 
4.5. Conclusion 
 
 In conclusion, the bonding and angiogenic behavior of (P)HxAlGltns was evaluated. 
(P)HxAlGltns-SLR4/1 had superior bonding strength to the porcine intestine surface compared with (P)AlGltns. 
Angiogenic markers including CD34 and -SMA were highly expressed around (P)HxAlGltn-SLR4/1 in all films. 
These results indicated that (P)HxAlGltns-SLR4/1, with a porosity of 62%, has potential for use as a tissue 
adhesive material as well as a scaffold for tissue engineering without the use of growth factors.
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Chapter 5 
 
Pore Size Impact on Angiogenesis and Bonding 
Strength in Hexanoyl Group Modified Gelatin 
Adhesive Films  
  
 
5.1. Summary 
 
 The relationship between wet tissue adhesion, the ability to stimulate angiogenesis and pore size of 
hexanoyl (Hx: C6) group modified, alkaline-treated gelatin (HxAlGltn)-porous films ((P)HxAlGltn) was evaluated. 
(P)HxAlGltn was fabricated via salt-leaching using 43, 77, 156 or 375 m diameter NaCl particles in a 4/1 
(w/w)-solid-liquid ratio ((P43)-, (P77)-, (P156)-, and (P375)HxAlGltn). Among all (P)HxAlGltns and (P)AlGltns, 
(P77)HxAlGltn bound strongest to porcinal intestine, and showed the fastest water absorption out of the films 
evaluated.  (P77)HxAlGltn also showed high cellular infiltration, and the fastest degradation out of the films 
tested when implanted in rat subcutaneous tissue. The infiltrated cells inside (P77)HxAlGltn showed much 
peroxidase expression. The (P43)HxAlGltn-tissue interface showed the largest CD34 positive area after 3 days 
implantation in rat subcutaneous tissue. These results indicate that strong bonding between (P)HxAlGltn and 
tissue is a result of body fluid absorption speed dependent on pore size and Hx group modification. Additionally, 
inflammatory reactions were found to be important in angiogenesis, and smaller pore sizes were found to induce 
mild inflammation and early angiogenesis. 
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5.2. Introduction 
 
 Materials that promote rapid wound healing without scar tissue formation are desperately needed in the 
clinic. For this purpose, several clinical adhesives have been investigated1-4. These adhesives, however, have poor 
bonding ability in wet tissues, forcing surgeons to rely on suturing to promote tissue healing. Suturing, however, 
wastes operation time and carries the possibility of infection5,6. It follows that adhesives with the ability to bond 
strongly to wet tissues with little to no inflammatory response could potentially supersede sutures.  
These adhesives could potentially be effective scaffolds for tissue regeneration. Liquid type adhesives 
can be applied to any tissue surface morphology7-9, however, premade adhesives are better suited for 
scaffolding10-16. There are now a number of biomaterials with internally connected spaces that have been designed 
as scaffolds to facilitate effective tissue regeneration11,12,17-19. In these scaffolds, material pore size is crucial to 
control of cytokine, antibody and cellular infiltration. The tissue regeneration is also depend on appropriate 
degradation, and it is crucial to control cells to produce growth factors and matrix proteases20-22. Therefore, 
sophisticated regulation of cellular regulation: appropriate inflammation, material degradation and angiogenesis is 
needed to allow for rapid tissue healing.  
Angiogenesis regulation is another important factor for tissue regeneration20-22. Rapid angiogenesis 
results in favorable tissue regeneration in many organs and tissues23-25. In order to accelerate angiogenesis, 
biomaterials with angiogenic factors have been developed, but these factors are expensive, and there are problems 
regulating factor release26-28. 
We have previously developed a hydrophobically modified gelatin (hm-Gltn) adhesive for clinical 
use29-34. In liquid, solid, and film morphologies, hm-Gltn materials bond strongly to wet tissue surfaces as long as 
both adhesive and tissue interfaces react with hydrophobic groups anchored to the tissue surface. Alkaline-treated 
Gltn modified with hexanoyl group (Hx: C6) (HxAlGltn) based highly porous films bound strongly to wet tissue. 
Moreover, we found that HxAlGltn had a high affinity to vascular endothelial growth factor (VEGF).  
We hypothesized that the regulation of pore size in HxAlGltn based porous films can control wound 
healing via cellular infiltration and growth factor release to the porous film. Our aim in this study was to clarify 
the relationship between bonding strength and angiogenesis to HxAlGltn pore size. To accomplish this goal, bulk 
characterization, bonding strength, water absorbency measurements, and tissue reaction quantification of the 
porous film were completed. 
 
Chapter 5 
72 
 
5.3. Materials and Methods 
 
 
5.3.1. Materials 
 
  BeMatrix®, or alkaline-treated gelatin (AlGltn) derived from porcine skin was kindly donated by Nitta 
Gelatin Inc. (Osaka, Japan). Ethanol (EtOH), dimethylsulfoxide (DMSO), triethylamine (TEA), 
2,4,6-trinitorobenzoylsurfonic acid (TNBS), hydrochloric acid (HCl), sodium dodecyl sulfide (SDS), 10% 
formalin neutral buffer solution, tertially-buthylalcohol and sodium chloride (NaCl) were purchased from Wako 
Pure Chemical Industries, Ltd. (Osaka, Japan). Hexanoyl (Hx: C6) chloride was purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Porcine intestine was purchased from Funakoshi Corporation (Tokyo, Japan). 
Phosphate buffered saline (PBS) was purchased from Lonza (Basel, Switzerland). 
2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8) was purchased 
from Dojindo Laboratories (Kumamoto, Japan). All chemicals were used without further purification. 
 
 
5.3.2. Synthesis and Characterization of HxAlGltn 
 
 Based on former reports29-32, the Hx group introduced into the hm-AlGltn (HxAlGltn) was prepared by 
reaction between Hx chloride and the primary amino groups of AlGltn. First, AlGltn (10 g) was fully dissolved 
into 99 mL of dehydrated DMSO at 80 ̊C. Following this step, one mL of hexanoyl chloride was added into the 
AlGltn/DMSO solution to obtain 100 mL of 10 w/v% AlGltn/DMSO solution under a dry N2 atmosphere at room 
temperature. Triethylamine (TEA) was subsequently added to the AlGltn solution and was stirred for 17h at room 
temperature. The resulting HxAlGltn/DMSO solution was then poured into 300 mL of cold EtOH and stirred for 1 
h. Subsequently, the HxAlGltn precipitate was washed twice with 300 mL of cold EtOH followed by evaporation 
under vacuum. Yields were then calculated. 
The modification ratio of Hx groups in HxAlGltn was quantified by the method previously reported 
using 2,4,6-trinitrobenzensulfonicacid (TNBS)29-32,42. Briefly, HxAlGltns or original AlGltn was dissolved into 
DMSO to obtain 0.05 w/v% solutions. After this, 100 L of 0.1 v/v% TEA/DMSO, 50 L of 0.1 w/v% 
SDS/DMSO and 100 L of 0.1 w/v% TNBS/DMSO were added to 100 L of HxAlGltn or AlGltn/DMSO 
solution followed by incubation at 37 C̊ for 2h under light shielding conditions. Following this, 50 L of 2 
N-HCl/DMSO was added to quench the reaction. Finally, light absorbance intensity was measured 
spectrophotometrically at 340 nm using a microplate-reader (GENios A-5082, Tecan Japan Kanagawa, Japan). 
The substitution percentage of amino groups with Hx chloride was then calculated from the intensities of 
HxAlGltn compared with the original AlGltn. 
  
 
 
 
Pore Size Impact on Angiogenesis and Bonding Strength in Hexanoyl Group Modified Gelatin Adhesive Films 
73 
 
5.3.3. Preparation and Characterization of (P)HxAlGltns and (P)AlGltns  
 
 HxAlGltn was first dissolved in DMSO to prepare a 25 w/v% solution. Required amounts of TSC were 
then added into 10 mL HxAlGltn/DMSO solution, and the TSC-HxAlGltn/DMSO was stirred quickly. NaCl 
particles were sieved into 5 sizes: 43, 77, 156 and 375 m in diameter. The required amount of NaCl (the 
liquid-solid ratio was 4/1) was added to the solution and mixed, allowing for uniform NaCl dispersion. The 
solution was then packed into a zipper bag (Unipack, Seisannipponsha ltd, Tokyo, Japan) and the HxAlGltn 
solution including NaCl were put between glass plates with 1 mm thick silicone spacers. After overnight 
cross-linking, the NaCl-HxAlGltn gels were immersed into 4 ̊C ultra-pure water for 3 days with frequent water 
changing to remove DMSO, NaCl, unreacted TSC and  side products including n-hydroxysuccinimide (NHS). The 
hydrogels were frozen at -80 ̊C, and were lyophilized for 3 days to obtain a (P)HxAlGltn film. AlGltn was used to 
fabricate (P)AlGltn films using the same technique as described above. 
 
 
5.3.4. Measurement of the Mechanical Strength of (P)HxAlGltns 
 
 Each film was cut out into 5 mm × 1 mm shapes, and both sides were bonded on 5 mm × 1 cm plastic 
sheets by GelBoy (LOCTITE, Japan Henkel, Japan) in a 2.5 mm × 5 mm area. After drying at room temperature, 
both plastic ends were clipped by probes, and tensile tests at 10 mm/minute speed were performed for all samples 
before and after 37 ̊C –water immersion (n = 3). 
 
 
5.3.5. Measurement of Bonding Strength Between Intestine and (P)HxAlGltns and (P)AlGltns and 
Observation of the Peeling Interfaces 
 
 The following measurement method was applied as previously reported33,34. Porcinal intestine was 
dissected with a dermal punch into disks of 4 mm in diameter. The dissected intestine was bonded onto a probe 
with GelBoy®. The porous films were also punched out into a 7 mm diameter circle shape, and placed on a heated 
plate at 37 C̊. They were then fixed with scotch tape (3M, Tokyo, Japan) with a hole of 4 mm diameter. The 
bonding strength was then measured using a Texture Analyzer (TA-XT2i, Stable Microsystems, UK) (n = 3) using 
the following parameters: 180 seconds contact time, 40 g/mm2 pressure and 10 mm/minute tracking speed. 
After the bonding strength measurement, each sample was fixed with 10% formalin neutral buffer 
solution followed by hematoxylin and eosin (H&E) staining. Each cross-section of the stained samples was 
observed with an optical microscope (BX51, Olympus, Tokyo, Japan). 
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5.3.6. Water Absorption Speed of the (P)HxAlGltns and (P)AlGltns 
 
 Two L of ultra-pure water was placed on the porous films at room temperature. The complete water 
absorption time (Ta) was determined, and the appearance of water on the films at each period was taken using a 
contact angle meter (DM800, Kyowa Interface Science Co. Ltd., Saitama, Japan) and FAMAS software (Kyowa 
Interface Science Co., Ltd.). The absorption speed of each film (Sa) was calculated by the following equation (n = 
3). 
Sa = 1/Ta 
 
5.3.7. Biodegradability and Tissue Infiltration Observation of the (P)HxAlGltns and (P)AlGltns 
Under Rat Subcutaneous Tissue 
 
 Each porous film was punched into 1 cm diameter disks, and sterilized with ethylene-oxide gas. The 
disks were implanted under rat subcutaneous tissue (Wister, 7weeks old, male) for 3, 7 and 14 days. After this 
period, each tissue including the porous film disk was removed. The amount of biodegradation in each film was 
examined by sight. The tissues-film compounds were then fixed in 10% formalin neutral buffer solution, and 
stained by H&E followed by light microscope observation. 
 
 
5.3.8. Inflammatory Evaluation of (P)HxAlGltns Under Rat Subcutaneous Implantation  
 
 After 10% formalin buffer fixation, the implanted (P)HxAlGltn and surrounding tissue were peroxidase 
stained. The peroxidase positive cells that infiltrated into the porous films were quantified by cellular counting 
under light microscopic observation (X51, Olympus). The areas infiltrated by cells were quantified with the 
ImageJ image analysis tool. 
 
 
5.3.9. Angiogenesis Evaluation Around (P)HxAlGltns and (P)AlGltns by CD34 and -SMA 
Immunostaining 
 
 The 10% formalin neutral buffer solution fixed samples were immunostained using CD34 and -SMA 
after 3, 7 and 14 days implantation. The CD34 or -SMA density per unit area was calculated by ImageJ imaging 
analysis. The applied gray scale value for CD34 expression quantification was under 100 and that for -SMA was 
under 170 (n = 3) , which gray scale value range was lower than that of nuclei and darker than that of other extra 
cellular matrix.  
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5.3.10. Statistical Analysis 
 
 Statistical analysis was carried out using Aspin-Welch’s t-test. Data are the means ± SD of three samples 
(n = 3). Statistically significant differences were accepted when p < 0.05. 
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5.4. Results and Discussion 
 
5.4.1. Preparation and Characterization of (P)HxAlGltns and (P)AlGltns with Regulated Pore Size 
 
 We previously reported that hexanoyl (Hx) chloride successfully reacts with the amino groups of the 
AlGltn molecules (Figure 5.1A). The number of amino groups substituted with Hx chlorides was determined 
using the 2,4,6-trinitrobenzensulfonicacid (TNBS) method. The Hx group modification ratio was 34%. 
(P)HxAlGltns, were fabricated through the use of salt leaching with 43, 77, 156, and 375 m-diameter NaCl 
combined with HxAlGltn films. The 34% modification ratio was reduced to a modification ratio of 25% by 
diluting HxAlGltn with AlGltn. The HxAlGltn molecule was then chemically cross-linked with a citrate acid 
derived cross-linker or trisuccinimidyl citrate (TSC) to make it water-insoluble. Finally, we obtained 
(P)HxAlGltns with each pore size: (P43)HxAlGltn, (P77)HxAlGltn, (P156)HxAlGltn, and (P375)HxAlGltn 
(Figure 5.1B). Figure 5.1C shows the cross sections of each dried porous film. The pore sizes were the almost 
same size within each film, and the pores were interconnected with the other pores. (P43)AlGltn, (P77)AlGltn, 
(P156)AlGltn, and (P375)AlGltn were also successfully fabricated using the same technique as (P)HxAlGltns 
fabrication. 
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Figure 5.1. Synthesis of HxAlGltn (A).Fabrication of the (P)HxAlGltns with each pore sizes by salt-leaching 
method (B). SEM images of the porous films with each pore size in dried state (C). 
 
The pore size inside the porous films was dependent on the NaCl particle sizes used during salt-leaching. 
The solid-liquid ratio (SLR) remained 4/1 (w/w), and each NaCl-HxAlGltn gel was fabricated in a 1 mm thick 
mold followed by water immersion and lyophilize. Therefore, only NaCl particle size was responsible for pore 
size of the porous films. 
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5.4.2. Mechanical Strength of (P)HxAlGltns (P)AlGltns 
 
 The mechanical strengths of the dry and wet porous films were measured. The strength of the dried 
(P)HxAlGltns film drastically decreased from 77 to 156 m NaCl size (Figure 5.2A). The strength of the wet 
(P)HxAlGltns, however, showed different behavior. In these films, (P77)HxAlGltn was strongest(Figure 5.2B). 
On the other hand, (P)AlGltns behaved very differently from (P)HxAlGltns in terms of strength. The (P77)AlGltn 
was the weakest in all the (P)AlGltns under dry conditions while (P156)AlGltn was the weakest under wet 
conditions. 
Larger pores inside solid materials like ceramics weaken mechanical stability (pore size: 6 to 490 m)35. 
On the other hand, larger pores inside soft materials like hyaluronan-collagen tend to improve mechanical stability 
(pore size: 123 to 182 m36 or 302.5 to 525 m37). Further, other research groups have found that the polymer 
composition significantly affects polymer strength for each porous body38. It can be hypothesized that 
(P)HxAlGltn and (P)AlGltn behaved differently due to the Hx group. In the dry state, (P)HxAlGltn showed solid 
material like mechanical strength due to its inner Hx group aggregation. On the other hand, (P)AlGltn without 
hydrophobic aggregation behaved like a softer material.   
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Figure 5.2. Bulk strength of (A) dry and (B) wet (P)HxAlGltns (●) and (P)AlGltn (○) . N=3. 
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5.4.3. Bonding Strength Measurements and Peeling Surface Observation between Porcinal 
Intestine and (P)HxAlGltns/(P)AlGltns 
 
(P77)HxAlGltn bound strongest to wet porcinal intestine out of the (P)HxAlGltns and the (P)AlGltns 
films. Further, (P)HxAlGltn bonding strengths were more than 1.7 times greater than the bonding strength of 
(P)AlGltns (Figure 5.3A). However, the strength of (P)AlGltn decreased with pore size increases. After the 
measurement, tissue that adhered to the film, and film that adhered to the tissue were observed.  Tissue with high 
cellularity adhered to (P77)HxAlGltn, (P43)HxAlGltn, and (P375)HxAlGltn. (P43)HxAlGltn and (P77)HxAlGltn 
film remnants remained on the tissue. Tissue remnants with low cellularity remained on the (P43)AlGltn and 
(P375)AlGltn films while (P156)AlGltn remnants remained on the tissue.  
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Figure 5.3. (A) Bonding strength between porcinal intestine and (P)HxAlGltn (●) or (P)AlGltn (○) with each 
pore size. (B) Tissue-(P)AlGltn interfaces after bonding strength measurement. (C) Tissue-(P)HxAlGltn interfaces 
after bonding strength measurement. Arrows: film or tissue remained on the surface. N=3, * p < 0.05, bar: 50 m. 
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The above result suggests that Hx group anchoring into the tissue surface is important for 
tissue:(P)HxAlGltn binding. In addition to the effect of Hx anchoring, the bulk strength of the films could also 
affect bonding strength. Therefore, we evaluated the bulk strength of the films in both the wet and dry state. In the 
dry condition, both (P43)AlGltn and (P43)HxAlGltn showed higher bulk strength (Figure 5.2A). However, in the 
wet condition, (P77)HxAlGltn showed the highest bulk strength in the (P)HxAlGltns while (P43)AlGltn showed 
the highest bulk strength in all the (P)AlGltns (Figure 5.2B). It can be hypothesized that the tissue-porous film 
interface was wet while the film body distant from the interface was dry. (P77)HxAlGltn had a high bulk strength 
in both the wet and dry state. Therefore, (P77)HxAlGltn had the strongest bonding strength compared with the 
other (P)HxAlGltns. 
 
 
5.4.4. Water Absorption Speed of (P)HxAlGltns and (P)AlGltns 
 
(P)HxAlGltns absorbed water much faster than the (P)AlGltns (Figure 5.4A). The water absorption 
speed of (P77)HxAlGltn was the greatest out of all films tested followed by (P43)HxAlGltn, (P156)HxAlGltn, 
(P231)HxAlGltn, and (P375)HxAlGltn in that order. The water absorption speed of (P)AlGltns decreased 
inversely with pore size.   
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Figure 5.4. (A) Water absorption speed of (P)HxAlGltns (●) and (P)AlGltns (○) with each pore size. Pictures of 
water drop on (P)AlGltns (B) or (P)HxAlGltns (C) at each measuring time point. The parenthetic values are the 
complete water absorption time. N = 3, *p < 0.05, #p < 0.05, ##p > 0.05. 
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It is well known that the capillary phenomenon impacts rapid liquid absorption. The rapid water 
absorption seen with (P77)HxAlGltn may have come from the bivalent hydrophilicity of HxAlGltn or the 
hydrophobically modified gelatin molecule. Hydrophilic polymers easily absorb water, but do not allow for the 
diffusion of water. On the other hand, hydrophobic polymers have a difficult time absorbing water, but have little 
problem allowing for the diffusion of water. And the application of those polymers properties in moisture 
permeable membrane is the combination of such. Those properties of the hydrophilic and hydrophobic polymers 
have been applied in moisture permeable membranes, or water vapor permeability studies39,40. In this study, 
simultaneous water flux in and out in the (P)HxAlGltns could potentially have facilitated optimal water absorption 
resulting in much faster absorption speed compared to the (P)AlGltns. 
 
 
5.4.5. Biodegradability and Tissue Infiltration in (P)HxAlGltns Implants under Rat Subcutaneous 
Tissue 
 
(P)HxAlGltn was punched 1 cm diameter disc, and each disc was implanted under rat subcutaneous 
tissue for 3, 7 and 14 days as three separate experiments (n=3). (P43)-, (P77)-, and (P156)HxAlGltn were smaller 
than (P375)HxAlGltn at 7 days implantation.  (P375)HxAlGltn was still present at 14 days implantation, 
however no (P43)-, (P77)-, (P156)-HxAlGltn was left at this time point. (Figure 5.5A). 
Based on complete (P43)-, (P77)-, and (P156)HxAlGltns degradation after 14 days implantation, tissue 
infiltration and tissue-(P)HxAlGltn integration were observed after histological H&E staining (Figure 5.5B). At 
day 3, (P43)-, (P77)-, and (P156)HxAlGltn were easily distinguished from the rat subcutaneous tissue with clearly 
visible interfaces. By day 7, however, the tissue-(P)HxAlGltn interfaces were unclear and difficult to define.  
Those results indicate that (P)HxAlGltn requires certain degree of fine pore for faster 
biodegradation/integration to circumference. 
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Figure 5.5. (A) Biodegradation of (P)HxAlGltns with each pore size under rat subcutaneous. (B) H&E stained 
(P)HxAlGltns and the surrounding tissue after rat subcutaneous implantation. Arrows: porous film between rat 
subcutaneous tissue. Dashed line: interface of the porous film and the rat subcutaneous tissue. F: porous film, T: 
subcutaneous tissue. 
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5.4.6. Cell Infiltration in (P)HxAlGltns Implanted under Rat Subcutaneous Tissue 
 
 Many cells was observed at sight in the (P77)HxAlGltn pores 3 days post-implantation (Figure 5.6). 
Further, it is possible that (P)HxAlGltn degradation speed was related to cellular infiltration. We, therefore, 
counted cell numbers in the pores. The greatest number of the cells infiltrated into (P77)HxAlGltn (5.46 × 103 
mm-2) followed by (P156)- (2.82 × 103 mm-2) and (P44)HxAlGltn (0.65 × 103 mm-2) (Figure 5.7B). 
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Figure 5.6. Cells infiltrated into the porous cells under rat subcutaneous. H&E staining, dashed block: the 
magnified part, scale bar: 10 m. 
Pore Size Impact on Angiogenesis and Bonding Strength in Hexanoyl Group Modified Gelatin Adhesive Films 
83 
(B)
0
2
4
6
8
0 50 100 150 200
Inf
iltr
ate
d C
ell
 Nu
mb
er 
x1
03
(/m
m2
)
Mean NaCl Diameter (m)
***
(A) Mean NaCl Deameter
43m 77m 156m
x10
x100
x250
10m
100m
20m
 
Figure 5.7. H&E stained (P)HxAlGltns with cellular infiltration inside of the pore (A) and the cell numbers in the 
pore (B) after 3 days’ rat subcutaneous implantation. N = 3, *p < 0.05. 
 
Cells can pass through holes depending on cell size and hole diameter41. The cellular infiltration 
tendency in this study can be related to the pore size of each film. The cells are approximately 10 m in diameter. 
The size of through hole connecting each pores of (P43)HxAlGltn was too small for cell infiltration. On the other 
hand, the through hole in (P156)HxAlGltn compared with (P43)- and (P77)HxAlGltn could be much larger than 
the cell diameter. (P77)HxAlGltn had the most appropriate through hole size as significant cellular infiltration 
occurred in this film. Many of the cells had segment-shaped nuclei, and thus were likely neutrophils suggesting an 
inflammatory immune response. We immunostained the gels to verify this hypothesis. 
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5.4.7. Inflammatory Evaluation of (P)HxAlGltns Implants under Rat Subcutaneous Tissue 
 
 For evaluation of the inflammation inside the porous films, formalin fixed (P)HxAlGltns were treated 
with peroxidase post rat subcutaneous implantation. Figure 5.8A showed that there were more peroxidase positive 
cells that infiltrated (P77)HxAlGltn compared with (P43)HxAlGltn and (P156)HxAlGltn. Cell number 
quantification also found that the number of peroxidase positive cells was significant in (P77)HxAlGltn compared 
to (P43)HxAlGltn and (P156)HxAlGltn (Figure 5.8B). In addition, the cells around those films showed similar 
tendency as inside the films (data is not shown). This indicated that (P77)HxAlGltn was highly inflammatory 
compared to the other (P)HxAlGltns. These results suggest that in (P77)HxAlGltn, cells easily moved into the 
pores. These cells infiltrated in the (P77)HxAlGltn contacted with the surrounding film walls and the neighboring 
cells facilitated much crosstalk resulted in much more peroxidase production. 
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Figure 5.8. Inflammatory evaluation with peroxidase staining inside each (P)HxAlGltn. (A) Microscopic images 
of cells inside the (a) (P43)HxAlGltn, (b) (P77)HxAlGltn or (c) (P156)HxAlGltn. Cells colored brown (red 
arrows) are peroxidase positive. (B) Peroxidase positive cells inside the (P)HxAlGltns. *p < 0.05, n = 5. 
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5.4.8. Angiogenesis Evaluation around (P)HxAlGltns Implants by CD34 and -SMA 
Immunostaining under Rat Subcutaneous Tissue 
 
 Microvasculature may have developed during the process of cellular and tissue infiltration into the 
(P)HxAlGltns. Therefore, we stained for CD34 and -SMA in order to see whether angiogenesis had occurred in 
and around the (P)HxAlGltns after rat subcutaneous implantation. CD34 is an immature endothelial cell marker, 
and -SMA is a mature endothelial cell marker.  With the use of these two markers, early angiogenesis and the 
establishment of mature vasculature can be investigated.  
At day 3, (P43)HxAlGltn was rich in CD34 compared with (P77)- and (P156)HxAlGltn. At day 7, the 
CD34 area in and around (P43)HxAlGltn decreased. Meanwhile, no significant differences in -SMA area 
between the three (P)HxAlGltns through 3 to 7 days implantation were found. It was natural that CD34 decreased 
with time because immature endothelial were abundant during the early angiogenesis stage (Figure 5.9B)  
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Figure 5.9. CD34 and a-SMA expression around the tissue-(P)HxAlGltns interface after rat subcutaneous 
implantation. (A) 20 times magnified images. (B) CD34 or a-SMA abound area around each tissue-(P)HxAlGltn 
interfaces, black: 3 days implantation, white: 7 days implantation, n = 3, *p < 0.05. 
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Contrary to CD34, there was no significant difference in -SMA expression in and around the three 
(P)HxAlGltns through day 3 to 7 post implantation. However, the value at day 7 was a little greater in and around 
each (P)HxAlGltn, although the difference was not statistically significant (p > 0.05). A few immature endothelial 
turned into mature endothelial to express -SMA. However, mature endothelial expressing -SMA already 
existed prior to (P)HxAlGltn implantation making. The slight increase in -SMA expression from 3 to 7 days post 
implantation may have indicated immature to mature endothelial transition, and pre-existed micro vascular got 
matured. 
 
 (P)HxAlGltns films bonded stronger than all (P)AlGltns to wet porcinal intestine. This indicated that the 
Hx group on the (P)HxAlGltns surface strengthens the film-tissue interface interaction. This film-tissue 
interaction is likely mediated through hydrophobic bonding with the extra-cellular matrix and the lipid bilayer of 
cells.  In addition, (P77)HxAlGltn showed the strongest bonding to the wet tissue surface among all porous films 
tested. Further, (P77)HxAlGltn had the fastest water absorption rate showing that body fluid absorption speed 
controlled by pore size is important for strong adhesion (Figure 5.10A and B). 
On the other hand, many neutrophil-like cells and peroxidase positive neutrophil-like cells, which 
reacted more inflammatory than peroxidase negative neutrophil-like cells, in the (P77)HxAlGltn indicated that the 
inflammation level was higher in (P77)HxAlGltn than (P43)- and (P156)HxAlGltn. The infiltrated cells were 
around 10 m in diameter, and the through holes which connecting each pore in the (P77)HxAlGltn could be 
around 10 m. Each infiltrated cell was adjacent to the other cells in (P77)HxAlGltn pores (Figure 5.6 and 5.7A). 
Cell to (P)HxAlGltn wall and cell to cell contact increased the immune response and brought about peroxidase 
production (Figure 5.10C and D). 
CD34 expression around (P43)HxAlGltn at 3 days posts implantation indicated that smaller pores were 
better for early angiogenesis. In addition, there were fewer peroxidase positive cells in (P43)HxAlGltn than in 
(P77)- and (P156)HxAlGltn. These results suggest the initiation of angiogenesis is inversely related to the 
inflammatory properties of (P)HxAlGltns (Figure 5.10C and D). The infiltrated cell number in (P43)HxAlGltn 
was smaller than  (P156)HxAlGltn, while,  the numbers of peroxidase positive cells in (P43)- and (P156) were 
similar. However, the (P)HxAlGltn contact area of the cells in (P43)HxAlGltn was much larger than those in 
(P156)HxAlGltn. Each infiltrated cell in the (P43)HxAlGltn hardly contacted other cells (Figure 5.7A and 5.8Aa). 
On the other hand, cells that infiltrated the (P156)HxAlGltn film could contact other infiltrated cells. Those 
differences resulted in inflammation level and following angiogenesis extent. 
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Figure 5.10. The mechanism of strong binding between (P)HxAlGltn and intestine tissue surface as well as 
angiogenesis facilitation by (P)HxAlGltn. (A) Relationship between NaCl particle sizes and body fluid absorption. 
(B) Effects of (P)HxAlGltn strong binding to intestine. (C) Relationship between NaCl particle sizes and 
angiogenesis. (D) Mechanism for angiogenesis after (P)HxAlGltn implantation. 
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5.5. Conclusion 
 
 Porous Hx (C6) group modified AlGltn film adhesives ((P)HxAlGltns) were fabricated with NaCl 
particles that were 43, 77, 156, or 375 m in diameter ((P43)-, (P77)-, (P156)-, and (P375)HxAlGltn). 
(P)HxAlGltns, especially (P77)HxAlGltn, bound stronger than (P)AlGltns to the wet intestine surface. Further, 
(P77)HxAlGltn showed a number of advantages in terms of water absorption speed, cellular infiltration and 
biodegradation.  The cells that infiltrated the film were neutrophils that were identified through their segment 
shaped nuclei. In addition to the neutrophils, many more peroxidase positive cells found in the (P77)HxAlGltn 
film than in (P43)- and (P156)HxAlGltns films.  Significantly more CD34 expression was identified around 
(P43)HxAlGltns-tissue interface compared to (P77)- and (P156)HxAlGltn after 3 days rat subcutaneous 
implantation. These results indicate that bonding strength between (P)HxAlGltn depends on tissue fluid 
absorption while early angiogenesis depends on mild inflammation caused by cellular infiltration. 
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Chapter 6 
 
Concluding Remarks and Future Directions 
  
 
6.1. Concluding Remarks 
 
 This research focused on determining the wet tissue-bonding ability of adhesive films fabricated by 
hydrophobically modified alkali-treated porcine gelatin (hm-AlGltn). First, hm-AlGltn modified with each alkyl 
group and with each modification ratio was synthesized. The bonding between wet tissue and the hm-AlGltn flat 
films fabricated by the casting method was examined. The bonding between wet tissue and mechanically 
strengthened hm-AlGltn flat films by simple thermal crosslinking without any crosslinker was investigated. How 
the effects of porosity on porous hm-AlGltn films crosslinked by citrate-derived crosslinker affected binding to 
wet tissue, biodegradability, and angiogenesis were determined.  
 
 Chapter 1 introduces the background about adhesives and discusses the elements crucial for adhesive 
design. The adhesive location as a kind of wound dressings, the bonding mechanisms, and the adhesive styles are 
described. Citing previous literature and current research, we clarified the objectives of this study. 
 
 Chapter 2 described the effect of hydrophobic modification of flat film shaped gelatin on wet tissue 
bonding strength. Each alkyl group with each chain length was introduced into AlGltn to synthesize 
hydrophobically modified AlGltns. Then plane flat films were fabricated by the mold casting method without any 
crosslinking to clarify the molecular interaction/effect on wet tissue bonding strength without any mechanical 
interaction such as the effects of bulk strength. The shortest alkyl group or hexanoyl group modified AlGltn: 
HxAlGltn film bonded most strongly onto porcine intestine among all hm-AlGltn films, and we discovered that 
the modification ratio of Hx group affected the burst strength of wet porcinal intestine. These results indicate that 
shorter alkyl groups and greater modification ratios cause strong bonding to the intestine surface. Additionally, the 
hm-AlGltn film bonding to wet tissue was directly strengthened by hydrophobic group modification.   
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 Chapter 3 describes the relation between wet tissue-bonding strength and alkyl chain 
length/modification ratio of hm-AlGltn mechanically strengthened flat film by thermal crosslinking. In this 
experiment, the physical strengthening of the hm-AlGltn film relied on thermal crosslinking. The thermal 
crosslinking was intended to clarify the effect of hydrophobic group modification on bonding strength even under 
mechanically strengthened state, If chemically crosslinked, the crosslinker composition/compounds should have 
some effect on the hm-AlGltn films and the tissue interaction. To begin, thermally crosslinked hm-AlGltn films 
(t-hm-AlGltns) were fabricated by original AlGltn and hm-AlGltns with each alkyl group modification. Even with 
thermal crosslinking, HxAlGltn film (tHxAlGltn) with the greater modification ratio bonded most strongly to wet 
tissue. Furthermore, fibroblasts spread out a great deal on tHxAlGltn at early bonding stage. These results indicate 
that the hm-AlGltn film-wet tissue bonding strength and cellular reaction could be attributed to the shorter alkyl 
group modification and its greater modification ratio.  
 
 Chapter 4 describes the porosity effects of porous hm-AlGltn films crosslinked by citrate-derived 
crosslinker on the wet tissue bonding effect and on tissue reaction. As described above, the HxAlGltn flat film 
with/without thermal crosslinking bonded the strongest to wet tissue. Therefore, the effect of the porous structure 
of HxAlGltn film on wet tissue bonding and tissue reaction were examined. There are two properties in a porous 
body: porosity and pore size, and in this chapter, we focused on porosity with a constant pore size. At the 
beginning, porous hm-AlGltn films were fabricated by AlGltns or HxAlGltns ((P)AlGltns or (P)HxAlGltns) by a 
salt leaching method using 375-µm NaCl particle with each solid-liquid ratio (SLR): 0/1, 1/1, 2/1, 3/1, 4/1 and 5/1 
(w/w). The (P)HxAlGltn fabricated with 4/1 w/w SLR ((P)HxAlGltn-SLR4/1) bonded most strongly to wet 
porcine intestine among all the porous films. (P)HxAlGltn-SLR4/1 demonstrated the fast tissue infiltration, fast 
biodegradability, and great angiogenesis properties in the absence of growth factor additives. Moreover, compared 
with AlGltn, the HxAlGltn molecule showed high affinity to vascular endothelial growth factor (VEGF), 
indicating the competence of HxAlGltn in angiogenesis facilitation by growth factor attraction. These results 
suggested that (P)HxAlGltn with great porosity is superior in wet tissue bonding and tissue regeneration ability. 
 
 Chapter 5 describes the pore size effect of (P)HxAlGltns to wet tissue-bonding effect and tissue reaction. 
In Chapter 4, the porosity effects of (P)HxAlGltn in wet tissue bonding strength and tissue reaction were 
determined. To examine the porous effect, porous size effect on bonding strength and angiogenesis should be also 
elucidated. On the other hand, it is well known that capillarity depends on the pore size and that body fluid 
absorption is responsible for porous film adhesivity. Therefore, (P)HxAlGltns and (P)AlGltn with each pore size 
were prepared by a salt leaching method with 43, 77, 156, or 375-µm NaCl particle in 4/1 w/w SLR. All the 
(P)HxAlGltns at each pore size showed greater water absorption speed, especially, (P77)HxAlGltn absorbed the 
quickest indicating its superiority in 77-µm pore size and Hx group modification. In wet tissue bonding strength 
measurement, (P)HxAlGltns, especially (P77)HxAlGltn, demonstrated advantages in bonding strength. 
(P)HxAlGltns with small pores degraded faster under rat subcutaneous tissue, and the greatest cellular number 
was counted in (P77)HxAlGltn pore at an early stage in vivo. However, (P)HxAlGltn with smaller pore size 
facilitated angiogenesis at an early stage in vivo. These results suggested that both pore size and Hx group 
modification of (P)HxAlGltn are responsible for strong bonding to wet tissue and facilitate angiogenesis. 
Chapter 6 
94 
 
 In conclusion, an hm-AlGltn film with advantages of wet tissue bonding and tissue reaction was 
developed in this study. The length and the modification ratio of the hydrophobic group on hm-AlGltn were 
directly related to the bonding strength. In addition, the constitution of the material affected the wet tissue bonding 
strength, tissue infiltration, biodegradation, and angiogenesis in vivo. This study determined that the shorter alkyl 
group-modified hm-AlGltns like ProAlGltn and HxAlGltn were more effective in wet tissue bonding, 
biodegradability, and angiogenesis. Among the (P)HxAlGltn film constitutions, SLR4/1 and 77 µm pore size were 
the most effective in wet tissue bonding while 43 µm pore size was the most effective for early stage angiogenesis 
in vivo. Regulation of the hydrophobic modification and the porous constitution will also be applied for adhesives 
to allow further control of bonding strength and tissue regeneration. 
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6.2. Future Directions 
 
 In this study, the effects of hydrophobic modification and porous constitution on wet tissue bonding and 
on tissue reaction were investigated, and it was determined that the bonding strength and tissue reaction can be 
controlled by the modification and constitution conditions. A current prospective application of this hm-AlGltn 
film is for use during surgery involving wound closure and for wound dressing with smooth continuous tissue 
reconstruction that leaves no scars.  
 
However, the angiogenesis facilitation ability of porous hm-AlGltn film by growth factor attraction 
suggested the modifications and the constitution could regulate other cytokines in vivo. Therefore, further 
modifications of gelatin molecules and the adhesive constitution could induce reactions including angiogenesis, 
rejuvenation, or cancer cell apoptosis.  
 
The porous hm-AlGltn films can be used in drug delivery. Medication control is crucial in some 
diseases like cancer, and intravenous drips, frequent injections, and frequent oral medications are time consuming, 
hard to precisely control, and are not ideal for the patient’s quality of life. Thus, medicine combined with 
adhesives to control its gradual release could be used in treatment. 
 
 The porous (P)hm-AlGltns can be applied for tissue engineering. The present study shows that the 
scaffold affects cellular differentiation. Some cells are difficult to retain at the unusual part, in other words, 
different tissues are difficult to connect in some cases. The adhesion property should be able to address those 
tissues. In addition, the (P)hm-AlGltn films provide an appropriate barrier with proper 3D environment for 
smooth connection of those tissues. The interconnected pores would provide smoother integration between tissues 
composed of cells with/without adhesiveness. 
  
Above all, adhesive biomaterials with specific molecular design and with regulated constitution are the 
future of efficient wound care/cure and novel tissue engineering (Figure 6.1) 
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Figure 6.1. Adhesive application with drug delivery and tissue regeneration property.
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